Cornelia Allaart
- Naam
- Dr. C.F. Allaart
- Telefoon
- +31 71 526 3598
- C.F.Allaart@umail.LeidenUniv.NL
- Faculteit Geneeskunde
- Divisie 2
- Reumatologie
- Ouwerkerk, L. van; Bergstra, S.A.; Maarseveen, T.D.; Huizinga, T.W.J.; Knevel, R. & Allaart, C.F. (2024), Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice?, Seminars in Arthritis and Rheumatism 64.
- Manaï, M.; Middendorp, H. van; Pol, J.A. van der; Allaart, C.F.; Dusseldorp, E.; Veldhuijzen, D.S.; Huizinga, T.W.J. & Evers, A.W.M. (2024), Can pharmacological conditioning as an add-on treatment optimize standard pharmacological treatment in patients with recent-onset rheumatoid arthritis? , Pharmaceuticals 17(1).
- Heckert, S.L.; Maassen, J.M.; Cessie, S. le; Goekoop-Ruiterman, Y.P.M.; Güler-Yüksel, M.; Lems, W.; Huizinga, T.W.; Bergstra, S.A. & Allaart, C.F. (2023), Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort, Annals of the Rheumatic Diseases.
- Spekking, K.; Anink, J.; Boer, P. de; Bergstra, S.A.; Berg, J.M. van den; Schonenberg-Meinema, D.; Suijlekom-Smit, L.W.A. van; Rossum, M.A.J. van; Koopman-Keemink, Y.; Cate, R.T.; Allaart, C.F.; Brinkman, D.M.C. & Muller, P.C.E.H. (2023), Significant pain decrease in children with non-systemic Juvenile Idiopathic Arthritis treated to target, Pediatric Rheumatology 21(1).
- Dam, K.P.J. van; Volkers, A.G.; Wieske, L.; Stalman, E.W.; Kummer, L.Y.L.; Kempen, Z.L.E. van; Killestein, J.; Tas, S.W.; Boekel, L.; Wolbink, G.J.; Kooi, A.J. van der; Raaphorst, J.; Takkenberg, R.B.; D'Haens, G.R.A.M.I.; Spuls, P.W.; Bekkenk, M.H.; Musters, A.F.; Post, N.L.; Bosma, A.L.; Hilhorst, M.; Vegting, Y.J.; Bemelman, F.E.; Voskuyl, A.; Broens, B.; Sanchez, A.P.; Els, C.A.C.M. van; Wit, J. de; Rutgers, A.; Leeuw, K. de; Horvath, B.; Verschuuren, J.J.G.M.M.; Ruiter, A.M.; Ouwerkerk, L. van; Woude, D. van der; Allaart, R.C.F.; Teng, Y.K.O.; Paassen, P.H. van; Busch, M.H.; Jallah, P.B.P.; Brusse, E.; Doorn, P.A. van; Baars, A.E.; Hijnen, D.J.; Schreurs, C.R.G.; Pol, W.L. van der; Goedee, H.S.; Steenhuis, M.; Keijzer, S.; Keijser, J.B.D.; Cristianawati, O.; Brinke, A. ten; Verstegen, N.J.M.; Ham, S.M. van; Rispens, T.W.; Kuijpers, T.; Lowenberg, M.; Eftimov, F. & TB2 Immunity Sars-Cov-2 Study Grp (2023), Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases, BMC Infectious Diseases 23(1).
- Pol, J.A. van der; Akdemir, G.; Broek, M. van den; Dirven, L.; Kerstens, P.J.S.M.; Lems, W.F.; Markusse, I.M.; Huizinga, T.W.J. & Allaart, C.F. (2023), Repair of joint damage in patients with rheumatoid arthritis does not relate to previous suppression of inflammation, RMD Open 9(2).
- Liem, S.I.E.; Ciaffi, J.; Leeuwen, N.M. van; Boonstra, M.; Ahmed, S.; Voorde, L.J.J. van de; Corsel, A.; Dhondai, T.; Ninaber, M.K.; Geelhoed-Veltman, J.J.M.; Heuvers, M.E.; Tushuizen, M.E.; Marsan, N.A.; Kies, P.; Schouffoer, A.A.; Huizinga, T.W.J.; Allaart, C.F. & Vries-Bouwstra, J. de (2023), Step forward in early recognition of systemic sclerosis, RMD Open 9(2).
- Ciaffi, J.; Liem, S.I.E.; Leeuwen, N.M. van; Allaart, C.F.; Huizinga, T.W.J. & Vries-Bouwstra, J.K. de (2023), Comment on, Rheumatology.
- Heckert, S.L.; Hissink-Muller, P.C.E.; Berg, J.M. van den; Schonenberg-Meinema, D.; Suijlekom-Smit, L.W.A. van; Rossum, M.A.J. van; Koopman, Y.; Cate, R. ten; Brinkman, D.M.C.; Huizinga, T.W.J.; Allaart, C.F. & Bergstra, S.A. (2023), Patterns of clinical joint inflammation in juvenile idiopathic arthritis, RMD Open 9(1).
- Eektimmerman, F.; Swen, J.J.; Broeder, A.A. den; Hazes, J.M.W.; Kurreeman, F.S.; Verstappen, S.M.M.; Nair, N.; Pawlik, A.; Nurmohamed, M.T.; Dolzan, V.; Bohringer, S.; Allaart, C.F. & Guchelaar, H.J. (2023), Genome-wide association study of methotrexate-induced liver injury in rheumatoid arthritis patients, Clinical Pharmacology & Therapeutics 113(4).
- Liem, S.I.E.; Neppelenbroek, S.; Fehres, C.M.; Wevers, B.A.; Toes, R.E.M.; Allaart, C.F.; Huizinga, T.W.J.; Scherer, H.U. & Vries-Bouwstra, J.K. de (2023), Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies, RMD Open 9(1).
- Wieske, L.; Stalman, E.W.; Dam, P.J.K. van; Kummer, L.Y.; Steenhuis, M.; Kempen, Z.L.E. van; Killestein, J.; Volkers, A.G.; Tas, S.W.; Boekel, L.; Wolbink, G.; Kooi, A. van der; Raaphorst, J.; Löwenberg, M.; Takkenberg, B.; D'Haens, G.R.A.M.; Spuls, P.I.; Bekkenk, M.W.; Musters, A.H.; Post, N.F.; Bosma, A.L.; Hilhorst, M.L.; Vegting, Y.; Bemelman, F.J.; Voskuyl, A.; Broens, B.; Sanchez, A.P.; Els, C.A.C.M. van; Wit, J. de; Rutgers, A.; Leeuw, K. de; Horváth, B.; Verschuuren, J.J.G.M.; Ruiter, A.M.; Ouwerkerk, L. van; Woude, D. van der; Allaart, C.F.; Teng, Y.K.O.; Paassen, P. van; Busch, M.H.; Jallah, P.B.P.; Brusse, E.; Doorn, P.A. van; Baars, A.E.; Hijnen, D.; Schreurs, C.R.G.; Pol, W.L. van der; Goedee, H.S.; Keijzer, S.; Keijser, J.; Cristianawati, O.; Brinke, A. ten; Verstegen, N.J.M.; Zwinderman, K.A.H.; Ham, S.M. van; Kuijpers, T.W.; Rispens, T.; Eftimov, F. & T2B Immunity SARS CoV 2 Study Grp (2023), Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases, Annals of the Rheumatic Diseases 82(6): 883-885.
- Ramiro, S.; Landewé, R.; Heijde, D. van der; Sepriano, A.; FitzGerald, O.; Ostergaard, M.; Homik, J.; Elkayam, O.; Thorne, J.C.; Larché, M.J.; Ferraccioli, G.; Backhaus, M.; Boire, G.; Combe, B.; Schaeverbeke, T.; Saraux, A.; Dougados, M.; Rossini, M.; Govoni, M.; Sinigaglia, L.; Cantagrel, A.G.; Allaart, C.F.; Barnabe, C.; Bingham, C.O. .I.I.I.; Schaardenburg, D. van; Hammer, H.B.; Dadashova, R.; Hutchings, E.; Paschke, J. & Maksymowych, W.P. (2023), Stricter treat-to-target in RA does not result in less radiographic progression, Rheumatology 62(9): 2989-2997.
- Dam, K.P.J. van; Wieske, L.; Stalman, E.W.; Kummer, L.Y.L.; Roosen, J.; Kempen, Z.L.E. van; Killestein, J.; Volkers, A.G.; Boekel, L.; Wolbink, G.J.; Kooi, A.J. van der; Raaphorst, J.; Löwenberg, M.; Takkenberg, R.B.; D'Haens, G.R.A.M.; Spuls, P.I.; Bekkenk, M.W.; Musters, A.H.; Post, N.F.; Bosma, A.L.; Hilhorst, M.L.; Vegting, Y.; Bemelman, F.J.; Voskuyl, A.E.; Broens, B.; Sanchez, A.P.; Els, C.A.C.M. van; Wit, J. de; Rutgers, A.; Leeuw, K. de; Horváth, B.; Verschuuren, J.J.G.M.; Ruiter, A.M.; Ouwerkerk, L. van; Woude, D. van der; Allaart, R.C.F.; Teng, Y.K.O.; Paassen, P. van; Busch, M.H.; Jallah, P.B.P.; Brusse, E.; Doorn, P.A. van; Baars, A.E.; Hijnen, D.J.; Schreurs, C.R.G.; Pol, W.L. van der; Goedee, H.S.; Steenhuis, M.; Keijzer, S.; Keijser, J.B.D.; Cristianawati, O.; Rispens, T.; Brinke, A. ten; Verstegen, N.J.M.; Ham, S.M. van; Tas, S.W.; Kuijpers, T.W.; Eftimov, F. & T2B Immunity SARS-CoV-2 Study Grp (2023), Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations, Journal of Autoimmunity 135.
- Heckert, S.L.; Bergstra, S.A.; Goekoop-Ruiterman, Y.P.M.; Gueler-Yueksel, M.; Lems, W.F.; Matthijssen, X.M.E.; Oosterhout, M. van; Huizinga, T.W.J. & Allaart, C.F. (2023), Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment, RMD Open 9(1).
- Ouwerkerk, L. van; Boers, M.; Emery, P.; Jong, P.H.P. de; Landewe, R.B.M.; Lems, W.; Smolen, J.S.; Verschueren, P.; Huizinga, T.W.J.; Allaart, C.F. & Bergstra, S.A. (2022), Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis, Annals of the Rheumatic Diseases 82(4).
- Stalman, E.W.; Wieske, L.; Dam, K.P.J. van; Kummer, L.Y.; Kempen, Z.L.E. van; Killestein, J.; Volkers, A.G.; Tas, S.W.; Boekel, L.; Wolbink, G.J.; Kooi, A.J. van der; Raaphorst, J.; Lowenberg, M.; Takkenberg, R.B.; D'Haens, G.R.A.M.; Spuls, P.I.; Bekkenk, M.W.; Musters, A.H.; Post, N.F.; Bosma, A.L.; Hilhorst, M.L.; Vegting, Y.; Bemelman, F.J.; Voskuyl, A.E.; Broens, B.; Sanchez, A.P.; Els, C.A.C.M. van; Wit, J. de; Rutgers, A.; Leeuw, K. de; Horvath, B.; Verschuuren, J.J.G.M.; Ruiter, A.M.; Ouwerkerk, L. van; Woude, D. van der; Allaart, C.F.; Teng, O.Y.K.; Paassen, P. van; Busch, M.H.; Jallah, P.B.P.; Brusse, E.; Doorn, P.A. van; Baars, A.E.; Hijnen, D.J.; Schreurs, C.R.G.; Pol, W.L. van der; Goedee, H.S.; Steenhuis, M.; Keijzer, S.; Keijser, J.B.D.; Boogaard, A.; Cristianawati, O.; Brinke, A. ten; Verstegen, N.J.M.; Zwinderman, K.A.H.; Rispens, T.; Ham, S.M. van; Kuijpers, T.W.; Eftimov, F. & T2B Immunity Against SARS Co (2022), Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases, Annals of the Rheumatic Diseases 81(12).
- Krijbolder, D.I.; Verstappen, M.; Dijk, B.T. van; Dakkak, Y.J.; Burgers, L.E.; Boer, A.C.; Park, Y.J.; Witt-Luth, M.E. de; Visser, K.; Kok, M.R.; Molenaar, E.T.H.; Jong, P.H.P. de; Böhringer, S.; Huizinga, T.W.J.; Allaart, C.F.; Niemantsverdriet, E. & Helm-van Mil, A.H.M. van der (2022), Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER) a randomised, double-blind, placebo-controlled, proof-of- concept trial, The Lancet 400(10348): 283-294.
- Krijbolder, D.I.; Verstappen, M.; Dijk, B.T. van; Dakkak, Y.J.; Burgers, L.E.; Boer, A.C.; Park, Y.J.; Witt-Luth, M.E. de; Visser, K.; Kok, M.R.; Molenaar, E.T.H.; Jong, P.H.P. de; Böhringer, S.; Huizinga, T.W.J.; Allaart, C.F.; Niemantsverdriet, E. & Helm-van Mil, A.H.M. van der (2022), Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER) a randomised, double-blind, placebo-controlled, proof-of- concept trial, The Lancet 400(10348): 283-294.
- Krijbolder, D.I.; Verstappen, M.; Dijk, B.T. van; Dakkak, Y.J.; Burgers, L.E.; Boer, A.C.; Park, Y.J.; Witt-Luth, M.E. de; Visser, K.; Kok, M.R.; Molenaar, E.T.H.; Jong, P.H.P. de; Böhringer, S.; Huizinga, T.W.J.; Allaart, C.F.; Niemantsverdriet, E. & Helm-van Mil, A.H.M. van der (2022), Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER) a randomised, double-blind, placebo-controlled, proof-of- concept trial, The Lancet 400(10348): 283-294.
- Krijbolder, D.I.; Verstappen, M.; Dijk, B.T. van; Dakkak, Y.J.; Burgers, L.E.; Boer, A.C.; Park, Y.J.; Witt-Luth, M.E. de; Visser, K.; Kok, M.R.; Molenaar, E.T.H.; Jong, P.H.P. de; Böhringer, S.; Huizinga, T.W.J.; Allaart, C.F.; Niemantsverdriet, E. & Helm-van Mil, A.H.M. van der (2022), Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER) a randomised, double-blind, placebo-controlled, proof-of- concept trial, The Lancet 400(10348): 283-294.
- Krijbolder, D.I.; Verstappen, M.; Dijk, B.T. van; Dakkak, Y.J.; Burgers, L.E.; Boer, A.C.; Park, Y.J.; Witt-Luth, M.E. de; Visser, K.; Kok, M.R.; Molenaar, E.T.H.; Jong, P.H.P. de; Böhringer, S.; Huizinga, T.W.J.; Allaart, C.F.; Niemantsverdriet, E. & Helm-van Mil, A.H.M. van der (2022), Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER) a randomised, double-blind, placebo-controlled, proof-of- concept trial, The Lancet 400(10348): 283-294.
- Krijbolder, D.I.; Verstappen, M.; Dijk, B.T. van; Dakkak, Y.J.; Burgers, L.E.; Boer, A.C.; Park, Y.J.; Witt-Luth, M.E. de; Visser, K.; Kok, M.R.; Molenaar, E.T.H.; Jong, P.H.P. de; Böhringer, S.; Huizinga, T.W.J.; Allaart, C.F.; Niemantsverdriet, E. & Helm-van Mil, A.H.M. van der (2022), Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER) a randomised, double-blind, placebo-controlled, proof-of- concept trial, The Lancet 400(10348): 283-294.
- Krijbolder, D.I.; Verstappen, M.; Dijk, B.T. van; Dakkak, Y.J.; Burgers, L.E.; Boer, A.C.; Park, Y.J.; Witt-Luth, M.E. de; Visser, K.; Kok, M.R.; Molenaar, E.T.H.; Jong, P.H.P. de; Böhringer, S.; Huizinga, T.W.J.; Allaart, C.F.; Niemantsverdriet, E. & Helm-van Mil, A.H.M. van der (2022), Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER) a randomised, double-blind, placebo-controlled, proof-of- concept trial, The Lancet 400(10348): 283-294.
- Krijbolder, D.I.; Verstappen, M.; Dijk, B.T. van; Dakkak, Y.J.; Burgers, L.E.; Boer, A.C.; Park, Y.J.; Witt-Luth, M.E. de; Visser, K.; Kok, M.R.; Molenaar, E.T.H.; Jong, P.H.P. de; Böhringer, S.; Huizinga, T.W.J.; Allaart, C.F.; Niemantsverdriet, E. & Helm-van Mil, A.H.M. van der (2022), Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER) a randomised, double-blind, placebo-controlled, proof-of- concept trial, The Lancet 400(10348): 283-294.
- Krijbolder, D.I.; Verstappen, M.; Dijk, B.T. van; Dakkak, Y.J.; Burgers, L.E.; Boer, A.C.; Park, Y.J.; Witt-Luth, M.E. de; Visser, K.; Kok, M.R.; Molenaar, E.T.H.; Jong, P.H.P. de; Böhringer, S.; Huizinga, T.W.J.; Allaart, C.F.; Niemantsverdriet, E. & Helm-van Mil, A.H.M. van der (2022), Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER) a randomised, double-blind, placebo-controlled, proof-of- concept trial, The Lancet 400(10348): 283-294.
- Krijbolder, D.I.; Verstappen, M.; Dijk, B.T. van; Dakkak, Y.J.; Burgers, L.E.; Boer, A.C.; Park, Y.J.; Witt-Luth, M.E. de; Visser, K.; Kok, M.R.; Molenaar, E.T.H.; Jong, P.H.P. de; Bohringer, S.; Huizinga, T.W.J.; Allaart, C.F.; Niemantsverdriet, E. & Helm-van Mil, A.H.M. van der (2022), Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER) , The Lancet 400(10348): 283-294.
- Ouwerkerk, L. van; Woude, D. van der; Rispens, T.; Allaart, C.F. & Huizinga, T.W.J. (2022), Presence of SARS-CoV-2 antibodies in patients with COVID-19 like symptoms from the IENIMINI cohort, Scandinavian Journal of Rheumatology 52(2).
- Meulen, C. van der; Stadt, L.A. van de; Kroon, F.P.B.; Kortekaas, M.C.; Boonen, A.E.R.C.H.; Bohringer, S.; Niesters, M.; Reijnierse, M.; Rosendaal, F.R.; Riyazi, N.; Starmans-Kool, M.; Turkstra, F.; Zeben, J. van; Allaart, C.F. & Kloppenburg, M. (2022), Neuropathic-like pain symptoms in inflammatory hand osteoarthritis lower quality of life and may not decrease under prednisolone treatment, European Journal of Pain 26(8): 1691-1701.
- Boekel, L.; Stalman, E.W.; Wieske, L.; Hooijberg, F.; Dam, K.P.J. van; Besten, Y.R.; Kummer, L.Y.L.; Steenhuis, M.; Kempen, Z.L.E. van; Killestein, J.; Volkers, A.G.; Tas, S.W.; Kooi, A.J. van der; Raaphorst, J.; Lowenberg, M.; Takkenberg, R.B.; D'Haens, G.R.A.M.; Spuls, P.I.; Bekkenk, M.W.; Musters, A.H.; Post, N.F.; Bosma, A.L.; Hilhorst, M.L.; Vegting, Y.; Bemelman, F.J.; Voskuyl, A.E.; Broens, B.; Sanchez, A.P.; Els, C.A.C.M. van; Wit, J. de; Rutgers, A.; Leeuw, K. de; Horvath, B.; Verschuuren, J.J.G.M.; Ruiter, A.M.; Ouwerkerk, L. van; Woude, D. van der; Allaart, C.F.; Teng, Y.K.O.; Paassen, P. van; Busch, M.H.; Jallah, P.B.P.; Brusse, E.; Doorn, P.A. van; Baars, A.E.; Hijnen, D.J.; Schreurs, C.R.G.; Pol, W.L. van der; Goedee, H.S.; Vogelzang, E.H.; Leeuw, M.; Atiqi, S.; Vollenhoven, R. van; Gerritsen, M.; Horst-Bruinsma, I.E. van der; Lems, W.F.; Nurmohamed, M.T.; Boers, M.; Keijzer, S.; Keijser, J.; Sandt, C. van de; Boogaard, A.; Cristianawati, O.; Brinke, A. ten; Verstegen, N.J.M.; Zwinderman, K.A.H.; Ham, S.M. van; Rispens, T.; Kuijpers, T.W.; Wolbink, G. & Eftimov, F. (2022), Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants , The Lancet Rheumatology 4(6): E417-E429.
- Kissel, T.; Hafkenscheid, L.; Wesemael, T.J.; Tamai, M.; Kawashiri, S.Y.; Kawakami, A.; El-Gabalawy, H.S.; Schaardenburg, D.; Rantapaa-Dahlqvist, S.; Wuhrer, M.; Mil, A.H.M.V.V.; Allaart, C.F.; Woude, D.; Scherer, H.U.; Toes, R.E.M. & Huizinga, T.W.J. (2022), IgG Anti-Citrullinated Protein Antibody Variable Domain Glycosylation Increases Before the Onset of Rheumatoid Arthritis and Stabilizes Thereafter: A Cross-Sectional Study Encompassing ∼1,500 Samples, Arthritis & Rheumatology 74(7): 1147-1158.
- Boekel, L.; Stalman, E.W.; Wieske, L.; Hooijberg, F.; Dam, K.P.J. van; Besten, Y.R.; Kummer, L.Y.L.; Steenhuis, M.; Kempen, Z.L.E. van; Killestein, J.; Volkers, A.G.; Tas, S.W.; Kooi, A.J. van der; Raaphorst, J.; Löwenberg, M.; Takkenberg, R.B.; D'Haens, G.R.A.M.; Spuls, P.I.; Bekkenk, M.W.; Musters, A.H.; Post, N.F.; Bosma, A.L.; Hilhorst, M.L.; Vegting, Y.; Bemelman, F.J.; Voskuyl, A.E.; Broens, B.; Sanchez, A.P.; Els, C.A.C.M. van; Wit, J. de; Rutgers, A.; Leeuw, K. de; Horváth, B.; Verschuuren, J.J.G.M.; Ruiter, A.M.; Ouwerkerk, L. van; Woude, D. van der; Allaart, C.F.; Teng, Y.K.O.; Paassen, P. van; Busch, M.H.; Jallah, P.B.P.; Brusse, E.; Doorn, P.A. van; Baars, A.E.; Hijnen, D.J.; Schreurs, C.R.G.; Pol, W.L. van der; Goedee, H.S.; Vogelzang, E.H.; Leeuw, M.; Atiqi, S.; Vollenhoven, R. van; Gerritsen, M.; Horst-Bruinsma, I.E. van der; Lems, W.F.; Nurmohamed, M.T.; Boers, M.; Keijzer, S.; Keijser, J.; Sandt, C. van de; Boogaard, A.; Cristianawati, O.; Brinke, A. ten; Verstegen, N.J.M.; Zwinderman, K.A.H.; Ham, S.M. van; Rispens, T.; Kuijpers, T.W.; Wolbink, G. & Eftimov, F. (2022), Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies, The Lancet Rheumatology 4(6): E417-E429.
- Boekel, L.; Stalman, E.W.; Wieske, L.; Hooijberg, F.; Dam, K.P.J. van; Besten, Y.R.; Kummer, L.Y.L.; Steenhuis, M.; Kempen, Z.L.E. van; Killestein, J.; Volkers, A.G.; Tas, S.W.; Kooi, A.J. van der; Raaphorst, J.; Löwenberg, M.; Takkenberg, R.B.; D'Haens, G.R.A.M.; Spuls, P.I.; Bekkenk, M.W.; Musters, A.H.; Post, N.F.; Bosma, A.L.; Hilhorst, M.L.; Vegting, Y.; Bemelman, F.J.; Voskuyl, A.E.; Broens, B.; Sanchez, A.P.; Els, C.A.C.M. van; Wit, J. de; Rutgers, A.; Leeuw, K. de; Horváth, B.; Verschuuren, J.J.G.M.; Ruiter, A.M.; Ouwerkerk, L. van; Woude, D. van der; Allaart, C.F.; Teng, Y.K.O.; Paassen, P. van; Busch, M.H.; Jallah, P.B.P.; Brusse, E.; Doorn, P.A. van; Baars, A.E.; Hijnen, D.J.; Schreurs, C.R.G.; Pol, W.L. van der; Goedee, H.S.; Vogelzang, E.H.; Leeuw, M.; Atiqi, S.; Vollenhoven, R. van; Gerritsen, M.; Horst-Bruinsma, I.E. van der; Lems, W.F.; Nurmohamed, M.T.; Boers, M.; Keijzer, S.; Keijser, J.; Sandt, C. van de; Boogaard, A.; Cristianawati, O.; Brinke, A. ten; Verstegen, N.J.M.; Zwinderman, K.A.H.; Ham, S.M. van; Rispens, T.; Kuijpers, T.W.; Wolbink, G. & Eftimov, F. (2022), Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies, The Lancet Rheumatology 4(6): E417-E429.
- Boekel, L.; Stalman, E.W.; Wieske, L.; Hooijberg, F.; Dam, K.P.J. van; Besten, Y.R.; Kummer, L.Y.L.; Steenhuis, M.; Kempen, Z.L.E. van; Killestein, J.; Volkers, A.G.; Tas, S.W.; Kooi, A.J. van der; Raaphorst, J.; Löwenberg, M.; Takkenberg, R.B.; D'Haens, G.R.A.M.; Spuls, P.I.; Bekkenk, M.W.; Musters, A.H.; Post, N.F.; Bosma, A.L.; Hilhorst, M.L.; Vegting, Y.; Bemelman, F.J.; Voskuyl, A.E.; Broens, B.; Sanchez, A.P.; Els, C.A.C.M. van; Wit, J. de; Rutgers, A.; Leeuw, K. de; Horváth, B.; Verschuuren, J.J.G.M.; Ruiter, A.M.; Ouwerkerk, L. van; Woude, D. van der; Allaart, C.F.; Teng, Y.K.O.; Paassen, P. van; Busch, M.H.; Jallah, P.B.P.; Brusse, E.; Doorn, P.A. van; Baars, A.E.; Hijnen, D.J.; Schreurs, C.R.G.; Pol, W.L. van der; Goedee, H.S.; Vogelzang, E.H.; Leeuw, M.; Atiqi, S.; Vollenhoven, R. van; Gerritsen, M.; Horst-Bruinsma, I.E. van der; Lems, W.F.; Nurmohamed, M.T.; Boers, M.; Keijzer, S.; Keijser, J.; Sandt, C. van de; Boogaard, A.; Cristianawati, O.; Brinke, A. ten; Verstegen, N.J.M.; Zwinderman, K.A.H.; Ham, S.M. van; Rispens, T.; Kuijpers, T.W.; Wolbink, G. & Eftimov, F. (2022), Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies, The Lancet Rheumatology 4(6): E417-E429.
- Boekel, L.; Stalman, E.W.; Wieske, L.; Hooijberg, F.; Dam, K.P.J. van; Besten, Y.R.; Kummer, L.Y.L.; Steenhuis, M.; Kempen, Z.L.E. van; Killestein, J.; Volkers, A.G.; Tas, S.W.; Kooi, A.J. van der; Raaphorst, J.; Löwenberg, M.; Takkenberg, R.B.; D'Haens, G.R.A.M.; Spuls, P.I.; Bekkenk, M.W.; Musters, A.H.; Post, N.F.; Bosma, A.L.; Hilhorst, M.L.; Vegting, Y.; Bemelman, F.J.; Voskuyl, A.E.; Broens, B.; Sanchez, A.P.; Els, C.A.C.M. van; Wit, J. de; Rutgers, A.; Leeuw, K. de; Horváth, B.; Verschuuren, J.J.G.M.; Ruiter, A.M.; Ouwerkerk, L. van; Woude, D. van der; Allaart, C.F.; Teng, Y.K.O.; Paassen, P. van; Busch, M.H.; Jallah, P.B.P.; Brusse, E.; Doorn, P.A. van; Baars, A.E.; Hijnen, D.J.; Schreurs, C.R.G.; Pol, W.L. van der; Goedee, H.S.; Vogelzang, E.H.; Leeuw, M.; Atiqi, S.; Vollenhoven, R. van; Gerritsen, M.; Horst-Bruinsma, I.E. van der; Lems, W.F.; Nurmohamed, M.T.; Boers, M.; Keijzer, S.; Keijser, J.; Sandt, C. van de; Boogaard, A.; Cristianawati, O.; Brinke, A. ten; Verstegen, N.J.M.; Zwinderman, K.A.H.; Ham, S.M. van; Rispens, T.; Kuijpers, T.W.; Wolbink, G. & Eftimov, F. (2022), Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies, The Lancet Rheumatology 4(6): E417-E429.
- Boers, M.; Hartman, L.; Opris-Belinski, D.; Bos, R.; Kok, M.R.; Silva, J.A.P. da; Griep, E.N.; Klaasen, R.; Allaart, C.F.; Baudoin, P.; Raterman, H.G.; Szekanecz, Z.; Buttgereit, F.; Masaryk, P.; Klausch, L.T.; Paolino, S.; Schilder, A.M.; Lems, W.F.; Cutolo, M. & GLORIA Trial Consortium (2022), Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+, Annals of the Rheumatic Diseases 81(7).
- Boers, M.; Hartman, L.; Opris-Belinski, D.; Bos, R.; Kok, M.R.; Silva, J.A.P. da; Griep, E.N.; Klaasen, R.; Allaart, C.F.; Baudoin, P.; Raterman, H.G.; Szekanecz, Z.; Buttgereit, F.; Masaryk, P.; Klausch, L.T.; Paolino, S.; Schilder, A.M.; Lems, W.F.; Cutolo, M. & GLORIA Trial Consortium (2022), Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial, Annals of the Rheumatic Diseases 81(7): 925-936.
- Liem, S.I.E.; Hoekstra, E.M.; Bonte-Mineur, F.; Checa, C.M.; Schouffoer, A.; Allaart, C.F.; Huizinga, T.W.J.; Bergstra, S.A. & Vries-Bouwstra, J.K. de (2023), The effect of silver fibre gloves on Raynaud's phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial, Rheumatology 62: SI74-SI81.
- Liem, S.I.E.; Hoekstra, E.M.; Bonte-Mineur, F.; Checa, C.M.; Schouffoer, A.; Allaart, C.F.; Huizinga, T.W.J.; Bergstra, S.A. & Vries-Bouwstra, J.K. de (2022), The effect of silver fibre gloves on Raynaud's phenomenon in patients with systemic sclerosis, Rheumatology 62(SI).
- Wieske, L.; Dam, K.P.J. van; Steenhuis, M.; Stalman, E.W.; Kummer, L.Y.L.; Kempen, Z.L.E. van; Killestein, J.; Volkers, A.G.; Tas, S.W.; Boekel, L.; Wolbink, G.J.; Kooi, A.J. van der; Raaphorst, J.; Lowenberg, M.; Takkenberg, R.B.; D'Haens, G.R.A.M.; Spuls, P.I.; Bekkenk, M.W.; Musters, A.H.; Post, N.F.; Bosma, A.L.; Hilhorst, M.L.; Vegting, Y.; Bemelman, F.J.; Voskuyl, A.E.; Broens, B.; Sanchez, A.P.; Els, C.A.C.M. van; Wit, J. de; Rutgers, A.; Leeuw, K. de; Horvath, B.; Verschuuren, J.J.G.M.; Ruiter, A.M.; Ouwerkerk, L. van; Woude, D. van der; Allaart, R.C.F.; Teng, Y.K.O.; Paassen, P. van; Busch, M.H.; Jallah, P.B.P.; Brusse, E.; Doorn, P.A. van; Baars, A.E.; Hijnen, D.J.; Schreurs, C.R.G.; Pol, W.L. van der; Goedee, H.S.; Keijzer, S.; Keijser, J.B.D.; Boogaard, A.; Cristianawati, O.; Brinke, A. ten; Verstegen, N.J.M.; Zwinderman, K.A.H.; Ham, S.M. van; Kuijpers, T.W.; Rispens, T.; Eftimov, F. & T2B Immunity SARS-CoV-2 Study Grp (2022), Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants, The Lancet Rheumatology 4(5): E338-E350.
- Ouwerkerk, L. van; Palmowski, A.; Nevins, I.S.; Buttgereit, F.; Verschueren, P.; Smolen, J.S.; Landewe, R.B.M.; Bijlsma, J.J.W.; Kerschbaumer, A.; Westhovens, R.; Huizinga, T.W.J.; Allaart, C.F. & Bergstra, S.A. (2022), Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis, Annals of the Rheumatic Diseases 81.
- Veldman, A.B.; Allaart, C.F. & Vleggeert-Lankamp, C.L.A. (2022), The influence of reducing disease activity score on cervical spine deformity in rheumatoid arthritis: a systematic review, BioMed Research International 2022.
- Derksen, V.F.A.M.; Allaart, C.F.; Helm-Van Mil, A.H.M. van der; Huizinga, T.W.J.; Toes, R.E.M. & Woude, D. van der (2022), In rheumatoid arthritis patients, total IgA1 and IgA2 levels are elevated, Rheumatology.
- Lebouille-Veldman, A.B.; Spenkelink, D.; Allaart, C.F. & Vleggeert-Lankamp, C.L.A. (2022), The association between Disease Activity Score and rheumatoid arthritis-associated cervical deformity: radiological evaluation of the BeSt trial, Journal of Neurosurgery: Spine 38(4): 465-472.
- Wieske, L.; Kummer, L.Y.L.; Dam, K.P.J. van; Stalman, E.W.; Kooi, A.J. van der; Raaphorst, J.; Lowenberg, M.; Takkenberg, R.B.; Volkers, A.G.; D'Haens, G.R.A.M.; Tas, S.W.; Spuls, P.I.; Bekkenk, M.W.; Musters, A.H.; Post, N.F.; Bosma, A.L.; Hilhorst, M.L.; Vegting, Y.; Bemelman, F.J.; Killestein, J.; Kempen, Z.L.E. van; Voskuyl, A.E.; Broens, B.; Sanchez, A.P.; Wolbink, G.; Boekel, L.; Rutgers, A.; Leeuw, K. de; Horvath, B.; Verschuuren, J.J.G.M.; Ruiter, A.M.; Ouwerkerk, L. van; Woude, D. van der; Allaart, C.F.; Teng, Y.K.O.; Paassen, P. van; Busch, M.H.; Jallah, B.P.; Brusse, E.; Doorn, P.A. van; Baars, A.E.; Hijnen, D.; Schreurs, C.R.G.; Pol, W.L. van der; Goedee, H.S.; Steenhuis, M.; Rispens, T.; Brinke, A. ten; Verstegen, N.J.M.; Zwinderman, K.A.H.; Ham, S.M. van; Kuijpers, T.W.; Eftimov, F. & T2b Immunity SARS-CoV-2 Study Grp (2022), Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases, BMC Medicine 20(1).
- Pieterse, A.H.; Brandes, K.; Graaf, J. de; Boer, J.E. de; Labrie, N.H.M.; Knops, A.; Allaart, C.F.; Portielje, J.E.A.; Bos, W.J.W. & Stiggelbout, A.M. (2021), Fostering patient choice awareness and presenting treatment options neutrally, Medical Decision Making 42(3).
- Hartman, L.; Cutolo, M.; Bos, R.; Opris-Belinski, D.; Kok, M.R.; Griep-Wentink, H.J.R.M.; Klaasen, R.; Allaart, C.F.; Bruyn, G.A.W.; Raterman, H.G.; Voshaar, M.J.H.; Gomes, N.; Pinto, R.M.A.; Klausch, L.T.; Lems, W.F. & Boers, M. (2021), Medication adherence in older people with rheumatoid arthritis is lower according to electronic monitoring than according to pill count, Rheumatology 60(11): 5239-5246.
- Stadt, L.A. van de; Kroon, F.P.B.; Rosendaal, F.R.; Heijde, D. van der; Reijnierse, M.; Riyazi, N.; Slegte, R. de; Zeben, J. van; Allaart, C.F.; Kloppenburg, M. & Kortekaas, M.C. (2022), Real-time vs static scoring in musculoskeletal ultrasonography in patients with inflammatory hand osteoarthritis, Rheumatology 61(SI): SI65-SI72.
- Stadt, L.A. van de; Kroon, F.P.B.; Rosendaal, F.R.; Heijde, D. van der; Reijnierse, M.; Riyazi, N.; Slegte, R. de; Zeben, J. van; Allaart, C.F.; Kloppenburg, M. & Kortekaas, M.C. (2022), Real-time vs static scoring in musculoskeletal ultrasonography in patients with inflammatory hand osteoarthritis, Rheumatology 61(SI): SI65-SI72.
- Stadt, L.A. van de; Kroon, F.P.B.; Rosendaal, F.R.; Heijde, D. van der; Reijnierse, M.; Riyazi, N.; Slegte, R. de; Zeben, J. van; Allaart, C.F.; Kloppenburg, M. & Kortekaas, M.C. (2022), Real-time vs static scoring in musculoskeletal ultrasonography in patients with inflammatory hand osteoarthritis, Rheumatology 61(SI): SI65-SI72.
- Stadt, L.A. van de; Kroon, F.P.B.; Rosendaal, F.R.; Heijde, D. van der; Reijnierse, M.; Riyazi, N.; Slegte, R. de; Zeben, J. van; Allaart, C.F.; Kloppenburg, M. & Kortekaas, M.C. (2022), Real-time vs static scoring in musculoskeletal ultrasonography in patients with inflammatory hand osteoarthritis, Rheumatology 61(SI): SI65-SI72.
- Stadt, L.A. van de; Kroon, F.P.B.; Rosendaal, F.R.; Heijde, D. van der; Reijnierse, M.; Riyazi, N.; Slegte, R. de; Zeben, J. van; Allaart, C.F.; Kloppenburg, M. & Kortekaas, M.C. (2022), Real-time vs static scoring in musculoskeletal ultrasonography in patients with inflammatory hand osteoarthritis, Rheumatology 61(SI): SI65-SI72.
- Stadt, L.A. van de; Kroon, F.P.B.; Rosendaal, F.R.; Heijde, D. van der; Reijnierse, M.; Riyazi, N.; Slegte, R. de; Zeben, J. van; Allaart, C.F.; Kloppenburg, M. & Kortekaas, M.C. (2022), Real-time vs static scoring in musculoskeletal ultrasonography in patients with inflammatory hand osteoarthritis, Rheumatology 61(SI): SI65-SI72.
- Stadt, L.A. van de; Kroon, F.P.B.; Rosendaal, F.R.; Heijde, D. van der; Reijnierse, M.; Riyazi, N.; Slegte, R. de; Zeben, J. van; Allaart, C.F.; Kloppenburg, M. & Kortekaas, M.C. (2022), Real-time vs static scoring in musculoskeletal ultrasonography in patients with inflammatory hand osteoarthritis, Rheumatology 61(SI): SI65-SI72.
- Stadt, L.A. van de; Kroon, F.P.B.; Rosendaal, F.R.; Heijde, D. van der; Reijnierse, M.; Riyazi, N.; Slegte, R. de; Zeben, J. van; Allaart, C.F.; Kloppenburg, M. & Kortekaas, M.C. (2022), Real-time vs static scoring in musculoskeletal ultrasonography in patients with inflammatory hand osteoarthritis, Rheumatology 61(SI): SI65-SI72.
- Stadt, L.A. van de; Kroon, F.P.B.; Rosendaal, F.R.; Heijde, D. van der; Reijnierse, M.; Riyazi, N.; Slegte, R. de; Zeben, J. van; Allaart, C.F.; Kloppenburg, M. & Kortekaas, M.C. (2022), Real-time vs static scoring in musculoskeletal ultrasonography in patients with inflammatory hand osteoarthritis, Rheumatology 61(SI): SI65-SI72.
- Maassen, J.M.; Bergstra, S.A.; Chopra, A.; Govind, N.; Murphy, E.A.; Vega-Morales, D.; Huizinga, T.W.J. & Allaart, C.F. (2021), Phenotype and treatment of elderly onset compared with younger onset rheumatoid arthritis patients in international daily practice, Rheumatology 60(10): 4801-4810.
- Ouwerkerk, L. van; Meulen-de Jong, A.E. van de; Ninaber, M.K.; Teng, Y.K.O.; Huizinga, T.W. & Allaart, C.F. (2021), Prospective study into COVID-19-like symptoms in patients with and without immune-mediated inflammatory diseases or immunomodulating drugs.
- Maassen, J.M.; Sobrin, R.D.; Bergstra, S.A.; Goekoop, R.; Huizinga, T.W.J. & Allaart, C.F. (2021), Glucocorticoid discontinuation in patients with early rheumatoid and undifferentiated arthritis: a post-hoc analysis of the BeSt and IMPROVED studies, Annals of the Rheumatic Diseases 80(9): 1124-1129.
- (2021), Tapering of disease-modifying antirheumatic drugs: an overview for daily practice, The Lancet Rheumatology 3(9).
- Stadt, L.A. van de; Kroon, F.P.B.; Rosendaal, F.R.; Heijde, D. van der; Reijnierse, M.; Riyazi, N.; Slegte, R. de; Zeben, J. van; Allaart, C.F.; Kloppenburg, M. & Kortekaas, M.C. (2022), Real-time vs static scoring in musculoskeletal ultrasonography in patients with inflammatory hand osteoarthritis, Rheumatology 61(SI): SI65-SI72.
- Amkreutz, J.A.M.P.; Moel, E.C. de; Theander, L.; Willim, M.; Heimans, L.; Nilsson, J.A.; Karlsson, M.K.; Huizinga, T.W.J.; Akesson, K.E.; Jacobsson, L.T.H.; Allaart, C.F.; Turesson, C. & Woude, D. van der (2021), Association between bone mineral density and autoantibodies in patients with rheumatoid arthritis, Arthritis and Rheumatology 73(6): 921-930.
- Leeuwen, N.M. van; Liem, S.I.E.; Maurits, M.P.; Ninaber, M.; Marsan, N.A.; Allaart, C.F.; Huizinga, T.W.J.; Knevel, R. & Vries-Bouwstra, J.K. de (2021), Disease progression in systemic sclerosis.
- Habers, G.E.A.; Helm-van Mil, A.H.M. van der; Veldhuijzen, D.S.; Allaart, C.F.; Vreugdenhil, E.; Starreveld, D.E.J.; Huizinga, T.W.J. & Evers, A.W.M. (2021), Earlier chronotype in patients with rheumatoid arthritis (Jan, 10.1007/s10067-020-05546-x, 2021), Clinical Rheumatology 40: 0-0.
- Leeuwen, N.M. van; Liem, S.I.E.; Maurits, M.P.; Ninaber, M.; Marsan, N.A.; Allaart, C.F.; Huizinga, T.W.J.; Knevel, R. & Vries-Bouwstra, J.K. de (2021), Disease progression in systemic sclerosis, Rheumatology 60(3): 1565-1567.
- Habers, G.E.A.; Helm-van Mil, A.H.M. van der; Veldhuijzen, D.S.; Allaart, C.F.; Vreugdenhil, E.; Starreveld, D.E.J.; Huizinga, T.W.J. & Evers, A.W.M. (2021), Earlier chronotype in patients with rheumatoid arthritis, Clinical Rheumatology 40.
- Wind, M.; Hendriks, M.; Brussel, B.T.J. van; Eikenboom, J.; Allaart, C.F.; Lamb, H.J.; Siebelink, H.M.J.; Ninaber, M.K.; Geloven, N. van; Lith, J.M.M. van; Huizinga, T.W.J.; Rabelink, T.J.; Sueters, M. & Teng, Y.K.O. (2021), Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome, Lupus Science & Medicine 8(1).
- Wind, M.; Hendriks, M.; Brussel, B.T.J. van; Eikenboom, J.; Allaart, C.F.; Lamb, H.J.; Siebelink, H.M.J.; Ninaber, M.K.; Geloven, N. van; Lith, J.M.M. van; Huizinga, T.W.J.; Rabelink, T.J.; Sueters, M. & Teng, Y.K.O. (2021), Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome, Lupus Science & Medicine 8(1).
- Leeuwen, N.M. van; Maurits, M.; Liem, S.; Ciaffi, J.; Marsan, N.A.; Ninaber, M.; Allaart, C.; Dongen, H.G. van; Goekoop, R.; Huizinga, T.; Knevel, R. & Vries-Bouwstra, J. de (2021), New risk model is able to identify patients with a low risk of progression in systemic sclerosis, RMD Open 7(2).
- Niemantsverdriet, E.; Dakkak, Y.J.; Burgers, L.E.; Bonte-Mineur, F.; Steup-Beekman, G.M.; Kooij, S.M. van der; Boom, H.D.; Allaart, C.F.; Jong, P.H.P. de & Helm-van Mil, A.H.M. van der (2020), TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol, Trials 21(1).
- Niemantsverdriet, E.; Dakkak, Y.J.; Burgers, L.E.; Bonte-Mineur, F.; Steup-Beekman, G.M.; Kooij, S.M. van der; Boom, H.D.; Allaart, C.F.; Jong, P.H.P. de & Helm-van Mil, A.H.M. van der (2020), TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER), Trials 21(1).
- Vanier, A.; Smolen, J.S.; Allaart, C.F.; Vollenhoven, R. van; Verschueren, P.; Vastesaeger, N.; Saevarsdottir, S.; Visser, K.; Aletaha, D.; Combe, B. & Fautrel, B. (2020), An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databases, Rheumatology 59(8): 1842-1852.
- Bergstra, S.A.; Allaart, C.F.; Vega-Morales, D.; Buck, M. de; Murphy, E.; Escoto, K.S. & Huizinga, T.W.J. (2020), Body mass index and treatment survival in patients with RA starting treatment with TNF alpha-inhibitors, RMD Open 6(2).
- Ramiro, S.; Landewe, R.B.M.; Heijde, D. van der; Sepriano, A.; FitzGerald, O.; Ostergaard, M.; Homik, J.; Elkayam, O.; Thorne, J.C.; Larche, M.; Ferraccioli, G.; Backhaus, M.; Boire, G.; Combe, B.; Schaeverbeke, T.; Saraux, A.; Dougados, M.; Rossini, M.; Govoni, M.; Sinigaglia, L.; Cantagrel, A.G.; Allaart, C.F.; Barnabe, C.; Bingham, C.O.; Tak, P.P.; Schaardenburg, D. van; Hammer, H.B.; Dadashova, R.; Hutchings, E.; Paschke, J. & Maksymowych, W.P. (2020), Is treat-to-target really working in rheumatoid arthritis? , Annals of the Rheumatic Diseases 79(4): 453-459.
- Eektimmerman, F.; Swen, J.J.; Madhar, M.B.; Allaart, C.F. & Guchelaar, H.J. (2020), Predictive genetic biomarkers for the efficacy of methotrexate in rheumatoid arthritis: a systematic review, Pharmacogenomics Journal 20(2): 159-168.
- Bergstra, S.A.; Allaart, C.F. & Landewe, R.B.M. (2020), Response to: 'Catching the falling star: points to consider when using propensity scores' by Ouyang et al.
- Bergstra, S.A.; VanDer Pol, J.A.; Riyazi, N.; Goekoop-Ruiterman, Y.P.M.; Kerstens, P.J.S.M.; Lems, W.; Huizinga, T.W.J. & Allaart, C.F. (2020), Earlier is better when treating rheumatoid arthritis, RMD Open 6(1).
- Bergstra, S.A.; Allaart, C.F. & Landewe, R.B.M. (2019), Response to: 'Metering the METEOR in methotrexate failure: is propensity score a falling star?' by Ahmed et al, Annals of the Rheumatic Diseases 78(12).
- Moel, E.C. de; Rech, J.; Mahler, M.; Roth, J.; Vogl, T.; Schouffoer, A.; Goekoop, R.J.; Huizinga, T.W.J.; Allaart, C.F.; Toes, R.E.M.; Schett, G. & Woude, D. van der (2019), Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs, Arthritis Research and Therapy 21(1).
- Kroon, F.P.B.; Kortekaas, M.C.; Boonen, A.; Bohringer, S.; Reijnierse, M.; Rosendaal, F.R.; Riyazi, N.; Starmans, M.; Turkstra, F.; Zeben, J. van; Allaart, C.F. & Kloppenburg, M. (2019), Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial, Lancet 394(10213): 1993-2001.
- Kroon, F.P.B.; Kortekaas, M.C.; Boonen, A.; Bohringer, S.; Reijnierse, M.; Rosendaal, F.R.; Riyazi, N.; Starmans, M.; Turkstra, F.; Zeben, J. van; Allaart, C.F. & Kloppenburg, M. (2019), Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial, Lancet 394(10213): 1993-2001.
- Mullerlr, P.C.E.H.; Braak, W.G. van; Schreurs, D.; Nusman, C.M.; Bergstra, S.A.; Hemke, R.; Schonenberg-Meinema, D.; Berg, J.M. van den; Kuijpers, T.W.; Koopman-Keemink, Y.; Rossum, M.A.J. van; Suijlekom-Smit, L.W.A. van; Brinkman, D.M.C.; Allaart, C.F.; Cate, R. ten & Maas, M. (2019), No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis, Pediatric Rheumatology.
- Mullerlr, P.C.E.H.; Braak, W.G. van; Schreurs, D.; Nusman, C.M.; Bergstra, S.A.; Hemke, R.; Schonenberg-Meinema, D.; Berg, J.M. van den; Kuijpers, T.W.; Koopman-Keemink, Y.; Rossum, M.A.J. van; Suijlekom-Smit, L.W.A. van; Brinkman, D.M.C.; Allaart, C.F.; Cate, R. ten & Maas, M. (2019), No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis, Pediatric Rheumatology 17(1).
- Bergstra, S.A.; Couto, M.C.; Govind, N.; Chopra, A.; Escoto, K.S.; Murphy, E.; Huizinga, T.W.J. & Allaart, C.F. (2019), Impact of the combined presence of erosions and ACPA on rheumatoid arthritis disease activity over time: results from the METEOR registry, RMD Open 5(2).
- Burgers, L.E.; Pol, J.A. van der; Huizinga, T.W.J.; Allaart, C.F. & Helm-van Mil, A.H.M. van der (2019), Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in routine care, Arthritis Research and Therapy 21.
- Bergstra, S.A.; Winchow, L.L.; Murphy, E.; Chopra, A.; Salomon-Escoto, K.; Fonseca, J.E.; Allaart, C.F. & Landewe, R.B.M. (2019), How to treat patients with rheumatoid arthritis when methotrexate has failed? The use of a multiple propensity score to adjust for confounding by indication in observational studies, Annals of the Rheumatic Diseases 78(1): 25-30.
- Muller, P.H.; Brinkman, D.M.C.; Schonenberg-Meinema, D.; Bosch, W.B. van den; Koopman-Keemink, Y.; Brederije, I.C.J.; Bekkering, P.W.; Kuijpers, T.W.; Rossum, M. van; Suijlekom-Smit, L.W.A. van; Berg, J.M. van den; Boehringer, S.; Allaart, C.F. & Cate, R. ten (2019), Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial, Annals of the Rheumatic Diseases 78(1): 51-59.
- Eektimmerman, F.; Allaart, C.F.; Hazes, J.M.W.; Broeder, A.A. den; Fransen, J.; Swen, J.J. & Guchelaar, H.J. (2019), Validation of a clinical pharmacogenetic model to predict methotrexate nonresponse in rheumatoid arthritis patients, Pharmacogenomics 20(2): 85-93.
- Moel, E.C. de; Derksen, V.F.A.M.; Trouw, L.A.; Bang, H.; Collee, G.; Lard, L.R.; Ramiro, S.; Huizinga, T.W.J.; Allaart, C.F.; Toes, R.E.M. & Woude, D. van der (2019), In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response, Arthritis Research and Therapy 21.
- Moel, E.C. de; Derksen, V.F.A.M.; Trouw, L.A.; Bang, H.; Goekoop-Ruiterman, Y.P.M.; Steup-Beekman, G.M.; Huizinga, T.W.J.; Allaart, C.F.; Toes, R.E.M. & Woude, D. van der (2018), In RA, becoming seronegative over the first year of treatment does not translate to better chances of drug-free remission, Annals of the Rheumatic Diseases 77(12): 1836-+.
- Bergstra, S.A.; Branco, J.C.; Vega-Morales, D.; Salomon-Escoto, K.; Govind, N.; Allaart, C.F. & Landewe, R.B.M. (2018), Inequity in access to bDMARD care and how it influences disease outcomes across countries worldwide: results from the METEOR-registry, Annals of the Rheumatic Diseases 77(10): 1413-1420.
- Bergstra, S.A.; Allaart, C.F.; Ramiro, S.; Chopra, A.; Govind, N.; Silva, C.; Murphy, E.A. & Landewe, R.B.M. (2018), Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR Register, Journal of Rheumatology 45(10): 1361-1366.
- Eektimmerman, F.; Swen, J.J.; Bohringer, S.; Aslibekyan, S.; Allaart, C.F. & Guchelaar, H.J. (2018), SLC04A1, SLC22A2 and SLC28A2 variants not related to methotrexate efficacy or toxicity in rheumatoid arthritis patients, Pharmacogenomics 19(7): 613-619.
- Bergstra, S.A. & Allaart, C.F. (2018), What is the optimal target for treat-to-target strategies in rheumatoid arthritis?, Current Opinion in Rheumatology 30(3): 282-287.
- Canhao, H.; Rodrigues, A.M.; Gregorio, M.J.; Dias, S.S.; Gomes, J.A.M.; Santos, M.J.; Faustino, A.; Costa, J.A.; Allaart, C.; Gvozdenovic, E.; Heijde, D. van der; Machado, P.; Branco, J.C.; Fonseca, J.E. & Silva, J.A. (2018), Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations, Frontiers in Medicine 5.
- Moel, E.C. de; Derksen, V.F.A.M.; Stoeken, G.; Trouw, L.A.; Bang, H.; Goekoop, R.J.; Speyer, I.; Huizinga, T.W.J.; Allaart, C.F.; Toes, R.E.M. & Woude, D. van der (2018), Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes, Arthritis Research and Therapy 20.
- Akdemir, G.; Markusse, I.M.; Bergstra, S.A.; Goekoop, R.J.; Molenaar, E.T.; Groenendael, J.H.L.M. van; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2018), Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis, RMD Open 4(1).
- Akdemir, G.; Heimans, L.; Bergstra, S.A.; Goekoop, R.J.; Oosterhout, M. van; Groenendael, J.H.L.M. van; Peeters, A.J.; Steup-Beekman, G.M.; Lard, L.R.; Sonnaville, P.B.J. de; Grillet, B.A.M.; Huizinga, T.W.J. & Allaart, C.F. (2018), Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study, Annals of the Rheumatic Diseases 77(1): 111-118.
- Allaart, C.F.; Markusse, I.M. & Lems, W.F. (2018), What have we learned from BeSt?, Clinical Immunology 186: 74-78.
- Muller, P.C.E.H.; Yildiz, B.; Allaart, C.F.; Brinkman, D.M.C.; Rossum, M. van; Suijlekom-Smit, L.W.A. van; Berg, J.M. van den; Cate, R. ten & Vries, M.C. de (2018), Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise?, BMC Medical Ethics.
- Bergstra, S.A.; Allaart, C.F.; Berg, R. van den; Chopra, A.; Govind, N.; Huizinga, T.W.J. & Landewe, R.B.M. (2017), Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis, Arthritis Research and Therapy 19.
- Bergstra, S.A.; Allaart, C.F.; Ramiro, S.; Chopra, A.; Silva, C.A.; Govind, N. & Landewe, R.B.M. (2017), Do We Treat Men and Women Differently, and Is This a Good Thing?, Arthritis and Rheumatology 69.
- Moel, E. de; Derksen, V.; Trouw, L.A.; Bang, H.; Goekoop-Ruiterman, Y.P.; Steup-Beekman, G.M.; Huizinga, T.W.J.; Allaart, C.F.; Toes, R.E.M. & Woude, D. van der (2017), In RA, Becoming Seronegative over the 1st Year of DMARD Treatment Does Not Improve Chances of Drug-Free Remission in the Long-Term, Arthritis and Rheumatology 69.
- Bergstra, S.A.; Allaart, C.F.; Stijnen, T. & Landewe, R.B.M. (2017), Meta-Regression of a Dose-Response Relationship of Methotrexate in Mono- and Combination Therapy in Disease-Modifying Antirheumatic Drug-Naive Early Rheumatoid Arthritis Patients.
- Pol, J.A. van der; Akdemir, G.; Broek, M. van den; Dirven, L.; Kerstens, P.J.S.M.; Lems, W.F.; Markusse, I.M.; Allaart, C.F. & Huizinga, T.W.J. (2017), Repair of Joint Damage Is Rare in Newly Diagnosed Rheumatoid Arthritis Patients and Appears Not to Relate to Previous Suppression of Inflammation, Arthritis and Rheumatology 69.
- Bergstra, S.A.; Landewe, R.B.M.; Huizinga, T.W.J. & Allaart, C.F. (2017), Rheumatoid arthritis patients with continued low disease activity have similar outcomes over 10 years, regardless of initial therapy, Rheumatology 56(10): 1721-1728.
- Muller, P.H.; Brinkman, D.; Schonenberg-Meinema, D.; Koopman-Keemink, Y.; Bosch, W. van den; Brederije, I.; Bekkering, P.; Kuijpers, T.; Rossum, M. van; Suijlekom-Smit, L. van; Berg, J.M. van den; Allaart, C.F. & Cate, R. ten (2017), Three Treatment Strategies in Recent Onset DMARD Naive Juvenile Idiopathic Arthritis: First Results of Clinical Outcome after 24 Months, Arthritis and Rheumatology 69.
- Bergstra, S.A.; Olivas, O.; Akdemir, G.; Riyazi, N.; Collee, G.; Groenendael, J.H.L.M. van; Landewe, R.B.M. & Allaart, C.F. (2017), Further Treatment Intensification in Undifferentiated and Rheumatoid Arthritis Patients Already in Low Disease Activity has Limited Benefit towards Physical Functioning, Arthritis Research and Therapy 19.
- Eektimmerman, F.; Swen, J.J.; Bohringer, S.; Huizinga, T.W.J.; Kooloos, W.M.; Allaart, C.F. & Guchelaar, H.J. (2017), Pathway analysis to identify genetic variants associated with efficacy of adalimumab in rheumatoid arthritis, Pharmacogenomics 18(10): 945-953.
- Tsuji, H.; Yano, K.; Furu, M.; Yamakawa, N.; Ikari, K.; Hashimoto, M.; Ito, H.; Fujii, T.; Yamamoto, W.; Ohmura, K.; Taniguchi, A.; Momohara, S.; Matsuda, F.; Allaart, C.F.; Yamanaka, H.; Mimori, T. & Terao, C. (2017), Time-averaged disease activity fits better joint destruction in rheumatoid arthritis, Scientific Reports 7.
- Vanier, A.; Smolen, J.; Allaart, C.; Vollenhoven, R. van; Verschueren, P.; Vastesaeger, N.; Saevarsdottir, S.; Visser, K.; Aletaha, D.; Combe, B. & Fautre, B. (2017), AN IMPROVED MATRIX TO PREDICT RAPID RADIOGRAPHIC PROGRESSION OF EARLY RHEUMATOID ARTHRITIS PATIENTS: POOLED ANALYSES FROM SEVERAL DATABASES, Annals of the Rheumatic Diseases 76: 158-158.
- Muller, P.H.; Meij, T.G.J. de; Westedt, M.; Groot, E.F.J. de; Allaart, C.F.; Brinkman, D.M.C.; Schonenberg-Meinema, D.; Berg, M. van den; Suijlekom-Smit, L.W.A. van; Rossum, M. van; Budding, A.E. & Cate, R. ten (2017), Disturbance of Microbial Core Species in New-Onset Juvenile Idiopathic Arthritis, Journal of Pediatric Infectious Diseases 12(2): 131-135.
- Bergstra, S.A.; Olivas, O.; Akdemir, G.; Riyazi, N.; Collee, G.; Groenendael, J.H. van; Landewe, R.B. & Allaart, C.F. (2017), FURTHER TREATMENT INTENSIFICATIONS IN UNDIFFERENTIATED AND RHEUMATOID ARTHRITIS PATIENTS ALREADY IN LOW DISEASE ACTIVITY HAVE LIMITED BENEFIT TOWARDS PHYSICAL FUNCTIONING, Annals of the Rheumatic Diseases 76: 793-793.
- Loef, M.; Kroon, F.P.; Bergstra, S.A.; Pol, J.A. van der; Lems, W.F.; Kerstens, P.J.; Allaart, C.F. & Kloppenburg, M. (2017), PROLONGED TNF-INHIBITOR TREATMENT DURATION IS ASSOCIATED WITH LOWER RISK OF HAND OSTEOARTHRITIS PROGRESSION IN PATIENTS WITH RECENT-ONSET RHEUMATOID ARTHRITIS AFTER 10-YEAR FOLLOW-UP, Annals of the Rheumatic Diseases 76: 976-976.
- Pol, J.A. van der; Akdemir, G.; Broek, M. van den; Dirven, L.; Kerstens, P.; Lems, W.F.; Markusse, I.M.; Huizinga, T.W. & Allaart, C.F. (2017), REPAIR OF JOINT DAMAGE IN NEWLY DIAGNOSED RHEUMATOID ARTHRITIS PATIENTS OCCURS BUT DOES NOT RELATE TO PREVIOUS SUPPRESSION OF INFLAMMATION; AN 8-YEARS SUB ANALYSIS IN THE BEST-COHORT, Annals of the Rheumatic Diseases 76: 516-516.
- Bergstra, S.A.; Landewe, R.B.; Huizinga, T.W. & Allaart, C.F. (2017), RHEUMATOID ARTHRITIS PATIENTS WITH CONTINUED LOW DISEASE ACTIVITY HAVE SIMILAR OUTCOMES OVER 10 YEARS, REGARDLESS OF INITIAL THERAPY, Annals of the Rheumatic Diseases 76: 160-160.
- Bergstra, S.A.; Allaart, C.F.; Berg, R. van den; Chopra, A.; Govind, N.; Huizinga, T.W.; Landewe, R.B. & METEOR Working Grp (2017), SIMILAR SHORT TERM CLINICAL RESPONSE TO INITIAL TREATMENT WITH HIGH VERSUS LOW DOSE METHOTREXATE IN MONO- AND COMBINATION THERAPY IN EARLY RHEUMATOID ARTHRITIS PATIENTS, Annals of the Rheumatic Diseases 76: 146-146.
- Mahmood, S.; Tuyl, L. van; Riel, P. van; Rongen, S.; Schaardenburg, D. van; Allaart, C.; Berg, R. van den; Moens, H. & Landewe, R. (2017), THE ASSESSMENT OF THE DUTCH QUALITY REGISTRY RHEUMATOID ARTHRITIS QUALITY INDICATORS IN THREE PILOT HOSPITALS, Annals of the Rheumatic Diseases 76: 434-434.
- Burgers, L.E.; Allaart, C.F.; Huizinga, T.W.J. & Helm-van Mil, A.H.M. van der (2017), Clinical Trials Aiming to Prevent Rheumatoid Arthritis Cannot Detect Prevention Without Adequate Risk Stratification: A Trial of Methotrexate Versus Placebo in Undifferentiated Arthritis as an Example, Arthritis and Rheumatology 69(5): 926-931.
- Akdemir, G.; Markusse, I.M.; Goekoop-Ruiterman, Y.P.M.; Steup-Beekman, G.M.; Grillet, B.A.M.; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2017), Rheumatologists' adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission, Clinical Rheumatology 36(2): 317-326.
- Muller, P.C.E.H.; Brinkman, D.M.C.; Schonenberg, D.; Koopman-Keemink, Y.; Brederije, I.C.J.; Bekkering, W.P.; Kuijpers, T.W.; Rossum, M.A.J. van; Suijlekom-Smit, L.W.A. van; Berg, J.M. van den; Allaart, C.F. & Cate, R. ten (2017), A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study, Pediatric Rheumatology 15.
- Cohen, D.; Rijnink, E.C.; Nabuurs, R.J.A.; Steup-Beekman, G.M.; Versluis, M.J.; Emmer, B.J.; Zandbergen, M.; Buchem, M.A. van; Allaart, C.F.; Wolterbeek, R.; Bruijn, J.A.; Duinen, S.G. van; Huizinga, T.W.J. & Bajema, I.M. (2017), Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement, Rheumatology 56(1): 77-86.
- Saevarsdottir, S.; Klareskog, L.; Hansson, M.; Eriksson, J.; Johannesson, M.; Holmdahl, R.; Skriner, K.; Serre, G.; Mathsson-Alm, L.; Vollenhoven, R.F. van; Woude, D. van der; Allaart, R.; Alfredsson, L.; McInnes, I.; Ronnelid, J. & Askling, J. (2016), Do specific ACPAs or other autoantibodies in a novel assay predict response to methotrexate monotherapy in patients with early and DMARD-naive RA?, Scandinavian Journal of Rheumatology 45: 19-19.
- Akdemir, G.; Markusse, I.M.; Goekoop-Ruiterman, Y.P.; Harbers, J.B.; Oosterhout, M. van; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2016), Assessment of Two Different DAS Treatment Targets in Early Active Rheumatoid Arthritis Patients, Arthritis and Rheumatology 68.
- Akdemir, G.; Heimans, L.; Goekoop, R.J.; Oosterhout, M. van; Harbers, J.B.; Bijkerk, C.; Steup-Beekman, G.M.; Lard, L.R.; Sonnaville, P.B.J. de; Grillet, B.A.M.; Huizinga, T.W.J. & Allaart, C.F. (2016), Clinical and Radiological Outcomes of 5 Years Remission Steered Treatment in Early Rheumatoid and Undifferentiated Arthritis Patients, Arthritis and Rheumatology 68.
- Burgers, L.E.; Allaart, C.F.; Huizinga, T.W.J. & Helm-van Mil, A.H.M. van der (2016), Clinical Trials Aiming to Prevent the Development of Rheumatoid Arthritis Cannot Detect Prevention without Adequate Risk Stratification; A Trial Performed in UA-Patients As Example, Arthritis and Rheumatology 68.
- Bergstra, S.A.; Landewe, R.B.M.; Huizinga, T.W.J. & Allaart, C.F. (2016), Comparison of 10-Years Disease Outcomes of Rheumatoid Arthritis Patients with Continued Low Disease Activity on Methotrexate with or without Initial Combination Therapy with Infliximab or Prednisone and Sulfasalazine, Arthritis and Rheumatology 68.
- Bergstra, S.A.; Allaart, C.F.; Stijnen, T. & Landewe, R.B.M. (2016), Dose-Related Short Term Clinical Response to Initial Treatment with Methotrexate in Mono- and Combination Therapy in Early Rheumatoid Arthritis Patients - a Meta-Regression Analysis, Arthritis and Rheumatology 68.
- Bergstra, S.A.; Vergara, O.M.O.; Akdemir, G.; Steup-Beekman, G.M.; Ronday, H.K.; Harbers, J.B.; Landewe, R.B.M. & Allaart, C.F. (2016), The Effect of Treatment Adjustments Aimed at DAS Remission on Physical Functioning in Undifferentiated and Rheumatoid Arthritis Patients in Low Disease Activity, Arthritis and Rheumatology 68.
- Sieberts, S.K.; Zhu, F.; Garcia-Garcia, J.; Stahl, E.; Pratap, A.; Pandey, G.; Pappas, D.; Aguilar, D.; Anton, B.; Bonet, J.; Eksi, R.; Fornes, O.; Guney, E.; Li, H.D.; Marin, M.A.; Panwar, B.; Planas-Iglesias, J.; Poglayen, D.; Cui, J.; Falcao, A.O.; Suver, C.; Hoff, B.; Balagurusamy, V.S.K.; Dillenberger, D.; Neto, E.C.; Norman, T.; Aittokallio, T.; Ammad-ud-din, M.; Azencott, C.A.; Bellon, V.; Boeva, V.; Bunte, K.; Chheda, H.; Cheng, L.; Corander, J.; Dumontier, M.; Goldenberg, A.; Gopalacharyulu, P.; Hajiloo, M.; Hidru, D.; Jaiswal, A.; Kaski, S.; Khalfaoui, B.; Khan, S.A.; Kramer, E.R.; Marttinen, P.; Mezlini, A.M.; Molparia, B.; Pirinen, M.; Saarela, J.; Samwald, M.; Stoven, V.; Tang, H.; Tang, J.; Torkamani, A.; Vert, J.P.; Wang, B.; Wang, T.; Wennerberg, K.; Wineinger, N.E.; Xiao, G.H.; Xie, Y.; Yeung, R.; Zhan, X.W.; Zhao, C.; Greenberg, J.; Kremer, J.; Michaud, K.; Barton, A.; Coenen, M.; Mariette, X.; Miceli, C.; Shadick, N.; Weinblatt, M.; Vries, N. de; Tak, P.P.; Gerlag, D.; Huizinga, T.W.J.; Kurreeman, F.; Allaart, C.F.; Bridges, S.L.; Criswell, L.; Moreland, L.; Klareskog, L.; Saevarsdottir, S.; Padyukov, L.; Gregersen, P.K.; Friend, S.; Plenge, R.; Stolovitzky, G.; Oliva, B.; Guan, Y.F.; Mangravite, L.M. & Rheumatoid Arth Challenge (2016), Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis, Nature Communications 7.
- Bergstra, S.A.; Markusse, I.M.; Akdemir, G.; Ronday, H.K.; Han, K.H.; Lems, W.F.; Kerstens, P.J.S.M.; Berg, R. van den; Landewe, R.B.M. & Allaart, C.F. (2016), Erosions in the foot at baseline are predictive of orthopaedic shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritis, Clinical Rheumatology 35(8): 2101-2107.
- Moghadam, M.G.; Vonkeman, H.E.; Klooster, P.M. ten; Tekstra, J.; Schaardenburg, D. van; Starmans-Kool, M.; Brouwer, E.; Bos, R.; Lems, W.F.; Colin, E.M.; Allaart, C.F.; Meek, I.L.; Landewe, R.; Moens, H.J.B.; Riel, P.L.C.M. van; Laar, M.A.F.J. van de; Jansen, T.L. & Dutch Natl POET Collaboration (2016), Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity, Arthritis and Rheumatology 68(8): 1810-1817.
- Bijlsma, J.W.J.; Welsing, P.M.J.; Woodworth, T.G.; Middelink, L.M.; Petho-Schramm, A.; Bernasconi, C.; Borm, M.E.A.; Wortel, C.H.; Borg, E.J. ter; Jahangier, Z.N.; Laan, W.H. van der; Bruyn, G.A.W.; Baudoin, P.; Wijngaarden, S.; Vos, P.A.J.M.; Bos, R.; Starmans, M.J.F.; Griep, E.N.; Griep-Wentink, J.R.M.; Allaart, C.F.; Heurkens, A.H.M.; Teitsma, X.M.; Tekstra, J.; Marijnissen, A.C.A.; Lafeber, F.P.J. & Jacobs, J.W.G. (2016), Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial, Lancet 388(10042): 343-355.
- Akdemir, G.; Markusse, I.M.; Ronday, H.K.; Speyer, I.; Harbers, J.B.; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2016), ADHERENCE TO DISEASE ACTIVITY SCORE STEERED TREATMENT PROTOCOLS IN EARLY ARTHRITIS PATIENTS, Annals of the Rheumatic Diseases 75: 454-455.
- Saevarsdottir, S.; Klareskog, L.; Hansson, M.; Eriksson, J.; Johannesson, M.; Holmdahl, R.; Skriner, K.; Serre, G.; Mathsson-Alm, L.; Vollenhoven, R.F. van; Woude, D. van der; Allaart, R.; Alfredsson, L.; McInnes, I.; Ronnelid, J.; Askling, J. & BeTheCure Consortium (2016), DO SPECIFIC ACPAS OR OTHER AUTOANTIBODIES MEASURED BY A NOVEL ASSAY PREDICT RESPONSE TO METHOTREXATE MONOTHERAPY IN PATIENTS WITH EARLY DMARD-NAIVE RA?, Annals of the Rheumatic Diseases 75: 696-696.
- Akdemir, G.; Heimans, L.; Goekoop, R.J.; Oosterhout, M. van; Harbers, J.B.; Bijkerk, C.; Steup-Beekman, G.M.; Lard, L.; Sonnaville, P.B.J. de; Grillet, B.A.M.; Huizinga, T.W.J. & Allaart, C.F. (2016), FIVE YEAR OUTCOMES OF REMISSION STEERED TREATMENT INCLUDING DRUG TAPERING STRATEGIES IN EARLY ARTHRITIS PATIENTS, Annals of the Rheumatic Diseases 75: 122-123.
- Bergstra, S.A.; Berg, R. van den; Chopra, A.; Silva, J.A.P. da; Vega-Morales, D.; Govind, N.; Allaart, C.F. & Landewe, R.B.M. (2016), INFLUENCE OF THE DIFFERENCE BETWEEN PATIENT AND PHYSICIAN GLOBAL ASSESSMENT ON DISEASE ACTIVITY STATUS IN HIGH AND LOWER INCOME COUNTRIES: DATA FROM THE METEOR DATABASE, Annals of the Rheumatic Diseases 75: 203-204.
- Ramiro, S.; Landewe, R.; Heijde, D. van der; FitzGerald, O.; Ostergaard, M.; Homik, J.; Elkayam, O.; Thorne, J.C.; Larche, M.; Ferraccioli, G.; Backhaus, M.; Boire, G.; Combe, B.; Schaeverbeke, T.; Saraux, A.; Dougados, M.; Adami, S.; Govoni, M.; Sinigaglia, L.; Cantagrel, A.; Allaart, C.F.; Barnabe, C.; Bingham, C.O.; Tak, P.P.; Schaardenburg, D. van; Hammer, H.B.; Dadashova, R.; Hutchings, E.; Paschke, J. & Maksymowych, W.P. (2016), IS TREAT-TO-TARGET REALLY WORKING? A LONGITUDINAL ANALYSIS IN BIODAM, Annals of the Rheumatic Diseases 75: 202-203.
- Akdemir, G.; Markusse, I.M.; Schouffoer, A.A.; Sonnaville, P.B. de; Grillet, B.A.; Kerstens, P.J.; Lems, W.F.; Huizinga, T.W. & Allaart, C.F. (2016), LOW DISEASE ACTIVITY OR DAS-REMISSION AS TREATMENT TARGET IN EARLY RHEUMATOID ARTHRITIS PATIENTS, Annals of the Rheumatic Diseases 75: 454-454.
- Markusse, I.M.; Dirven, L.; Han, K.H.; Ronday, H.K.; Sonnaville, P.B.J. de; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2016), Evaluating Adherence to a Treat-to-Target Protocol in Recent-Onset Rheumatoid Arthritis: Reasons for Compliance and Hesitation, ARTHRITIS CARE & RESEARCH 68(4): 446-453.
- Markusse, I.M.; Akdemir, G.; Dirven, L.; Goekoop-Ruiterman, Y.P.M.; Groenendael, J.H.L.M. van; Han, K.H.; Molenaar, T.H.E.; Cessie, S. le; Lems, W.F.; Lubbe, P.A.H.M. van der; Kerstens, P.J.S.M.; Peeters, A.J.; Ronday, H.K.; Sonnaville, P.B.J. de; Speyer, I.; Stijnen, T.; Wolde, S. ten; Huizinga, T.W.J. & Allaart, C.F. (2016), Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment, Annals of Internal Medicine 164(8): 523-+.
- Sanders, M.F.; Blankestijn, P.J.; Voskuil, M.; Spiering, W.; Vonken, E.J.; Rotmans, J.I.; Hoeven, B.L. van der; Daemen, J.; Meiracker, A.H. van den; Kroon, A.A.; Haan, M.W. de; , M. das; Bax, M.; Meer, I.M. van der; Overhagen, H. van; Born, B.J.H. van den; Brussel, P.M. van; Valk, P.H.M. van der; Gregoor, P.J.H.S.; Meuwissen, M.; Gomes, M.E.R.; Ophuis, T.O.; Troe, E.; Tonino, W.A.L.; Konings, C.J.A.M.; Vries, P.A.M. de; Balen, A. van; Heeg, J.E.; Smit, J.J.J.; Elvan, A.; Steggerda, R.; Niamut, S.M.L.; Peels, J.O.J.; Swart, J.B.R.M. de; Wardeh, A.J.; Groeneveld, J.H.M.; Linden, E. van der; Hemmelder, M.H.; Folkeringa, R.; Stoel, M.G.; Kant, G.D.; Herrman, J.P.R.; Wissen, S. van; Deinum, J.; Westra, S.W.; Aengevaeren, W.R.M.; Parlevliet, K.J.; Schramm, A.; Jessurun, G.A.J.; Rensing, B.J.W.M.; Winkens, M.H.M.; Wierema, T.K.A.; Santegoets, E.; Lipsic, E.; Houwerzijl, E.; Kater, M.; Allaart, C.P.; Nap, A. & Bots, M.L. (2016), Safety and long-term effects of renal denervation: Rationale and design of the Dutch registry, Netherlands Journal of Medicine 74(1): 5-15.
- Heimans, L.; Akdemir, G.; Wevers-de Boer, K.V.C.; Goekoop-Ruiterman, Y.P.; Molenaar, E.T.; Groenendael, J.H.L.M. van; Peeters, A.J.; Steup-Beekman, G.M.; Lard, L.R.; Sonnaville, P.B.J. de; Grillet, B.A.M.; Huizinga, T.W.J. & Allaart, C.F. (2016), Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study).
- Gvozdenovic, E.; Wolterbeek, R.; Heijde, D. van der; Huizinga, T.; Allaart, C. & Landewe, R. (2016), DAS steered therapy in clinical practice; cross-sectional results from the METEOR database, BMC Musculoskeletal Disorders 17.
- Terao, C.; Yamakawa, N.; Yano, K.; Markusse, I.M.; Ikari, K.; Yoshida, S.; Furu, M.; Hashimoto, M.; Ito, H.; Fujii, T.; Ohmura, K.; Murakami, K.; Takahashi, M.; Hamaguchi, M.; Tabara, Y.; Taniguchi, A.; Momohara, S.; Raychaudhuri, S.; Allaart, C.F.; Yamanaka, H.; Mimori, T. & Matsuda, F. (2015), Rheumatoid Factor Is Associated With the Distribution of Hand Joint Destruction in Rheumatoid Arthritis, Arthritis and Rheumatology 67(12): 3113-3123.
- Matthijssen, X.M.E.; Akdemir, G.; Markusse, I.M.; Goekoop-Ruiterman, Y.P.; Han, K.H.; Huidekoper, A.L.; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2015), Age Effects Joint Space Narrowing in Early Active Rheumatoid Arthritis Patients, Arthritis and Rheumatology 67.
- Gvozdenovic, E.; Wolterbeek, R.; Allaart, C.F.; Brenol, C.; Dougados, M.; Emery, P.; Ferraccioli, G.; Heijde, D. van der; Huizinga, T.W.J.; Kay, J.; Mola, E.M.; Moots, R.J.; Silva, J.A.P. da; Smolen, J.; Veale, D. & Landewe, R.B.M. (2015), Assessment of Global Disease Activity in Rheumatoid Arthritis by Patients and Physicians: Differences Across Countries in the METEOR Database, JCR: Journal of Clinical Rheumatology 21(7): 349-354.
- Akdemir, G.; Bijl, A.E. van der; Lange-Brokaar, B.J.E. de; Huizinga, T.W.J.; Allaart, C.F. & Kloppenburg, M. (2015), Inflammation Signs on Magnetic Resonance Imaging in Chronic or Recurrent Gonarthritis Treated with Intra-Articular Infliximab or Corticosteroids, Arthritis and Rheumatology 67.
- Ramiro, S.; Landewe, R.B.M.; Heijde, D. van der; FitzGerald, O.; Ostergaard, M.; Homik, J.; Elkayam, O.; Thorne, J.C.; Larche, M.; Ferraccioli, G.; Backhaus, M.; Boire, G.; Combe, B.; Schaeverbeke, T.; Saraux, A.; Dougados, M.; Adami, S.; Govoni, M.; Sinigaglia, L.; Cantagrel, A.G.; Allaart, C.F.; Barnabe, C.; Bingham, C.O.; Tak, P.P.; Schaardenburg, D. van; Hammer, H.B.; Dadashova, R.; Hutchings, E.; Paschke, J. & Maksymowych, W. (2015), Is Treat-to-Target Really Working? a Longitudinal Analysis in Biodam, Arthritis and Rheumatology 67.
- Moghadam, M.G.; Vonkeman, H.E.; Klooster, P.M. ten; Tekstra, J.; Schaardenburg, D. van; Starmans-kool, M.; Brouwer, E.; Bos, R.; Lems, W.F.; Colin, E.; Allaart, C.F.; Meek, I.L.; Landewe, R.B.M.; Moens, H.J.B.; Riel, P. van; Laar, M.A.F.J. van de; Jansen, T. & Dutch Natl POET Collaboration (2015), Pragmatic Multicenter Open-Label Randomized Controlled Trial of Stopping TNF-Inhibitors in Rheumatoid Arthritis Patients in Remission or Stable Low Disease Activity in the Netherlands, Arthritis and Rheumatology 67.
- Terao, C.; Yamakawa, N.; Yano, K.; Markusse, I.M.; Ikari, K.; Yoshida, S.; Furu, M.; Hashimoto, M.; Ito, H.; Fujii, T.; Ohmura, K.; Murakami, K.; Takahashi, M.; Hamaguchi, M.; Tabara, Y.; Taniguchi, A.; Momohara, S.; Raychaudhuri, S.; Allaart, C.F.; Yamanaka, H.; Mimori, T. & Matsuda, F. (2015), Rheumatoid Factor Is Associated with the Distribution of Hand Joint Destruction in a Dose-Dependent Manner, Arthritis and Rheumatology 67.
- Akdemir, G.; Markusse, I.M.; Groenendael, J.H.L.M. van; Peeters, A.J.; Molenaar, E.T.; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2015), Treatment Target in a Disease Activity Score Steered Treatment Protocol in Early Arthritis Patients: Low Disease Activity or Remission, Arthritis and Rheumatology 67.
- Heemst, J. van; Trouw, L.A.; Nogueira, L.; Steenbergen, H.W. van; Helm-van Mil, A.H.M. van der; Allaart, C.F.; Serre, G.; Holmdahl, R.; Huizinga, T.W.J.; Toes, R.E.M. & Woude, D. van der (2015), An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
- Wevers-De Boer, K.V.C.; Heimans, L.; Visser, K.; Schouffoer, A.A.; Molenaar, E.T.H.; Groenendael, J.H.L.M. van; Peeters, A.J.; Speyer, I.; Collee, G.; Huizinga, T.W.J. & Allaart, C.F. (2015), Determinants of reaching drug-free remission in patients with early rheumatoid or undifferentiated arthritis after one year of remission-steered treatment, Rheumatology 54(8): 1380-1384.
- Markusse, I.M.; Dirven, L.; Gerards, A.H.; Groenendael, J.H.L.M. van; Ronday, H.K.; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2015), Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study.
- Markusse, I.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2015), Response to 'Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis' - authors' reply.
- Markusse, I.M.; Dirven, L.; Han, K.H.; Ronday, H.K.; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2015), Continued Participation in a Ten-Year Tight Control Treat-to-Target Study in Rheumatoid Arthritis: Why Keep Patients Doing their Best?, ARTHRITIS CARE & RESEARCH 67(6): 739-745.
- Wevers-de Boer, K.V.C.; Heimans, L.; Visser, K.; Kalvesten, J.; Goekoop, R.J.; Oosterhout, M. van; Harbers, J.B.; Bijkerk, C.; Steup-Beekman, M.; Buck, M.P.D.M. de; Sonnaville, P.B.J. de; Huizinga, T.W.J. & Allaart, C.F. (2015), Four-month metacarpal bone mineral density loss predicts radiological joint damage progression after 1 year in patients with early rheumatoid arthritis: exploratory analyses from the IMPROVED study, Annals of the Rheumatic Diseases 74(2): 341-346.
- Heimans, L.; Wevers-de Boer, K.V.C.; Ronday, H.K.; Collee, G.; Sonnaville, P.B.J. de; Grillet, B.A.M.; Huizinga, T.W.J. & Allaart, C.F. (2015), Can we prevent rapid radiological progression in patients with early rheumatoid arthritis?, Clinical Rheumatology 34(1): 163-166.
- Maksymowych, W.P.; Heijde, D. van der; Allaart, C.F.; Landewe, R.; Boire, G.; Tak, P.P.; Gui, Y.; Ghahary, A.; Kilani, R. & Marotta, A. (2014), 14-3-3 eta is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage.
- Muller, P.C.E.H.; Brinkman, D.M.C.; Schonenberg, D.; Koopman-Keemink, Y.; Berg, J.M. van den; Bekkering, W.P.; Rossum, M. van; Suijlekom-Smit, L.W. van; Allaart, C.F. & Cate, R. ten (2014), A Comparison of Three Treatment Strategies in Recent Onset DMARD Naive Juvenile Idiopathic Arthritis: 3-Months Results of the BeSt for Kids-Study., Arthritis and Rheumatology 66(12): 3529-3530.
- Gvozdenovic, E.; Koevoets, R.; Langenhoff, J.; Allaart, C.F. & Landewe, R.B.M. (2014), Comparison of characteristics of international and national databases for rheumatoid arthritis: a systematic literature review, Scandinavian Journal of Rheumatology 43(5): 349-355.
- Markusse, I.M.; Vries-Bouwstra, J.K. de; Han, K.H.; Lubbe, P.A.H.M. van der; Schouffoer, A.A.; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2014), Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis.
- Markusse, I.M.; Dirven, L.; Broek, M. van den; Bijkerk, C.; Han, K.H.; Ronday, H.K.; Bolce, R.; Sasso, E.H.; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2014), A Multibiomarker Disease Activity Score for Rheumatoid Arthritis Predicts Radiographic Joint Damage in the BeSt Study, Journal of Rheumatology 41(11): 2114-2119.
- Marotta, A.; Schaardenburg, D. van; Boire, G.; Heijde, D. van der; Landewe, R.; Boers, M.; Allaart, C.F.; Murphy, M.; Turk, S.; Bykerk, V.P.; Keystone, E.; Siminovitch, K.A. & Maksymowych, W.P. (2014), Citrullinated 14-3-3 eta Antibodies Are Specific for Early and Established RA and Are Complementary to ACPA, Arthritis and Rheumatology 66: S152-S152.
- Canhao, H.; Martins, F.M.; Gomes, J.A.M.; Santos, M.J.; Faustino, A.; Costa, J.A.; Allaart, C.; Gvozdenovic, E.; Machado, P.; Branco, J.C.; Fonseca, J.E. & Da-Silva, J.P. (2014), Comparative Study of Rheumatoid Arthritis Disease Activity Indices in Two Populations of Meteor Database., Arthritis and Rheumatology 66: S1059-S1060.
- Markusse, I.M.; Dirven, L.; Molenaar, T.H.E.; Riyazi, N.; Sonnaville, P.B.J. de; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2014), Continued Participation in a 10-Year Tight Control Treat-to-Target Study in Rheumatoid Arthritis: Why Keep Patients Doing Their BeSt?, Arthritis and Rheumatology 66: S1045-S1045.
- Markusse, I.M.; Dirven, L.; Goekoop-Ruiterman, Y.P.; Lubbe, P.A. van der; Peeters, A.J.; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2014), Disease Flares during 10 Year Follow-up in Patients with Rheumatoid Arthritis Are Associated with Joint Damage Progression and Disability., Arthritis and Rheumatology 66: S611-S611.
- Markusse, I.M.; Dirven, L.; Groenendael, J.H. van; Han, K.H.; Ronday, H.K.; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2014), Mortality in a Large Cohort of Patients with Early Rheumatoid Arthritis That Were Treated-to-Target for 10 Years., Arthritis and Rheumatology 66: S359-S359.
- Akdemir, G.; Heimans, L.; Wevers-de Boer, K.V.C.; Verheul, M.K.; Schouffoer, A.A.; Oosterhout, M. van; Harbers, J.B.; Bijkerk, C.; Steup-Beekman, G.M.; Lard, L.R.; Huizinga, T.W.J.; Trouw, L.A. & Allaart, C.F. (2014), Radiological Outcomes after Two Years of Remission Steered Treatment in Early Arthritis Patients., Arthritis and Rheumatology 66: S935-S935.
- Markusse, I.M.; Akdemir, G.; Dirven, L.; Broek, M. van den; Han, K.H.; Ronday, H.K.; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2014), Ten Year Follow-up Results of Four Dynamic Treat to Target Strategies in Patients with ACPA Negative Rheumatoid Arthritis, Arthritis and Rheumatology 66: S1093-S1094.
- Markusse, I.M.; Akdemir, G.; Huizinga, T.W.J. & Allaart, C.F. (2014), Drug-free holiday in patients with rheumatoid arthritis: a qualitative study to explore patients' opinion, Clinical Rheumatology 33(8): 1155-1159.
- Heimans, L.; Wevers-de Boer, K.V.C.; Visser, K.; Goekoop, R.J.; Oosterhout, M. van; Harbers, J.B.; Bijkerk, C.; Speyer, I.; Buck, M.P.D.M. de; Sonnaville, P.B.J. de; Grillet, B.A.M.; Huizinga, T.W.J. & Allaart, C.F. (2014), A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study, Annals of the Rheumatic Diseases 73(7): 1356-1361.
- Markusse, I.; Dirven, L.; vd Broek, M.; Akdemir, G.; Goekoop-Ruiterman, Y.; Han, H.; Kerstens, P.; Lems, W.; Huizinga, T. & Allaart, C. (2014), 10 YEARS OF TREAT-TO-TARGET THERAPY IN RHEUMATOID ARTHRITIS PATIENTS (THE BEST STUDY): CLINICAL AND RADIOGRAPHIC OUTCOMES, Annals of the Rheumatic Diseases 73: 272-273.
- Akdemir, G.; Markusse, I.; Dirven, L.; Broek, M. van den; Molenaar, E.; Schouffoer, A.; Kerstens, P.; Lems, W.; Huizinga, T. & Allaart, C. (2014), ACPA-NEGATIVE RA PATIENTS BENEFIT FROM INITIAL COMBINATION THERAPY WITH EARLY CLINICAL IMPROVEMENT - A SUB-ANALYSIS OF THE BEST STUDY, Annals of the Rheumatic Diseases 73: 271-272.
- Gvozdenovic, E.; Allaart, C.; Wolterbeek, R.; Brenol, C.; Chopra, A.; Dougados, M.; Emery, P.; Ferraccioli, G.; Heijde, D. van der; Huizinga, T.; Kay, J.; Mola, E.; Moots, R.; Silva, J. da; Smolen, J.; Veale, D. & Landewe, R. (2014), ASSESSMENT OF GLOBAL DISEASE ACTIVITY IN RA BY PATIENTS AND PHYSICIANS: CULTURAL DIFFERENCES ACROSS COUNTRIES IN THE METEOR DATABASE, Annals of the Rheumatic Diseases 73: 336-336.
- Markusse, I.; Dirven, L.; Han, H.; Ronday, K.; Kerstens, P.; Lems, W.; Huizinga, T. & Allaart, C. (2014), GOOD ADHERENCE OF RHEUMATOLOGISTS TO A 10 YEAR TREAT-TO-TARGET PROTOCOL FOR PATIENTS WITH RECENT-ONSET RHEUMATOID ARTHRITIS (THE BEST STUDY), Annals of the Rheumatic Diseases 73: 401-401.
- Allaart, C.F. (2014), INVESTIGATOR-INITIATED CLINICAL TRIALS - HOW TO BE SUCCESSFUL, Annals of the Rheumatic Diseases 73: 22-22.
- Gvozdenovic, E.; Koevoets, R.; Wolterbeek, R.; Heijde, D. van der; Huizinga, T.W.J.; Allaart, C.F. & Landewe, R.B.M. (2014), Assessment of global disease activity in RA patients monitored in the METEOR database: the patient's versus the rheumatologist's opinion, Clinical Rheumatology 33(4): 461-466.
- Muhammad, A.; Wesemael, T. van; Kochi, Y.; Mjaavatten, M.D.; Wevers-de Boer, K.; Allaart, C.F.; Trouw, L.A.; Suzuki, A.; Yamamoto, K.; Helm-van Mil, A.H.M. van der; Huizinga, T.W.J.; Toes, R.E.M. & Woude, D. van der (2014), IN RHEUMATOID ARTHRITIS, SMOKING IS NOT PRIMARILY ASSOCIATED WITH ANTI-CITRULLINAGED PROTEIN ANTIBODIES, BUT WITH THE PRESENCE OF SEVERAL AUTOANTIBODIES, Annals of the Rheumatic Diseases 73: A12-A12.
- Gvozdenovic, E.; Dirven, L.; Broek, M. van den; Han, K.H.; Molenaar, E.T.H.; Landewe, R.B.M.; Lems, W.F. & Allaart, C.F. (2014), Intra articular injection with corticosteroids in patients with recent onset rheumatoid arthritis: subanalyses from the BeSt study, Clinical Rheumatology 33(2): 263-267.
- Muller, P.C.E.H.; Anink, J.; Shi, J.; Levarht, E.W.N.; Reinards, T.H.C.M.; Otten, M.H.; Tol, M.J.D. van; Jol-van der Zijde, C.M.; Brinkman, D.M.C.; Allaart, C.F.; Hoppenreijs, E.P.; Koopman-Keemink, Y.; Kamphuis, S.S.M.; Dolman, K.; Berg, J.M. van den; Rossum, M.A.J. van; Suijlekom-Smit, L.W.A. van; Schilham, M.W.; Huizinga, T.W.J.; Toes, R.E.M.; Cate, R. ten & Trouw, L.A. (2013), Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients, Annals of the Rheumatic Diseases 72(12): 2053-2055.
- Heimans, L.; Wevers-de Boer, K.V.C.; Koudijs, K.K.M.; Visser, K.; Goekoop-Ruiterman, Y.P.; Harbers, J.B.; Steup-Beekman, G.M.; Lard, L.R.; Grillet, B.A.M.; Huizinga, T.W.J. & Allaart, C.F. (2013), Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED study.
- Heimans, L.; Wevers-de Boer, K.; Visser, K.; Ronday, H.K.; Steup-Beekman, G.M.; Oosterhout, M. van; Huizinga, T.W.J.; Giltay, E.J.; Mast, R.C. van der & Allaart, C.F. (2013), The relationship between disease activity and depressive symptoms severity and optimism-results from the IMPROVED study, Clinical Rheumatology 32(12): 1751-1757.
- Markusse, I.M.; Akdemir, G.; Broek, M. van den; Dirven, L.; Goekoop, R.J.; Han, K.H.; Oosterhout, M. van; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Allaart, C.F. (2013), 10 Years Of Treat-To-Target Therapy In Rheumatoid Arthritis Patients (the BeSt study): Clinical and Radiological Outcomes, Arthritis and Rheumatism 65: S620-S620.
- Markusse, I.M.; Dirven, L.; Broek, M. van den; Han, K.H.; Lieshout, M.F. van; Riyazi, N.; Bolce, R.J.; Sasso, E.H.; Kerstens, P.J.S.M.; Lems, W.F.; Huizinga, T.W.J. & Bolce, R.J. (2013), A Multi-Biomarker Disease Activity Score For Rheumatoid Arthritis Predicts Radiographic Damage In The BeSt Study, Arthritis and Rheumatism 65: S569-S569.
- Gvozdenovic, E.; Wolterbeek, R.; Allaart, C.F.; Brenol, C.; Chopra, A.; Dougados, M.; Emery, P.; Heijde, D. van der; Huizinga, T.W.J.; Kay, J.; Mola, E.M.; Moots, R.J.; Silva, J.A.P. da; Smolen, J.S.; Veale, D.J. & Landewe, R. (2013), Assessment Of Global Disease Activity In Rheumatoid Arthritis By Patients and Physicians: Cultural Differences Among Countries In The Meteor Database., Arthritis and Rheumatism 65: S970-S971.
- Heimans, L.; Wevers-de Boer, K.V.C.; Akdemir, G.; Ronday, H.K.; Molenaar, T.H.E.; Groenendael, J.H.L.M. van; Peeters, A.J.; Speyer, I.; Collee, G.; Sonnaville, P.B. de; Grillet, B.A.; Huizinga, T.W.J. & Allaart, C.F. (2013), Clinical and Radiological Outcomes Of Two Years Remission Steered Treatment In Early Arthritis Patients, Arthritis and Rheumatism 65: S339-S339.
- Gvozdenovic, E.; Koevoets, R.; Langenhoff, J.; Allaart, C.F. & Landewe, R. (2013), Comparison Of Characteristics In Rheumatoid Arthritis Between International and National Databases In Europe: A Systematic Literature Review., Arthritis and Rheumatism 65: S43-S43.
- Markusse, I.M.; Akdemir, G.; Huizinga, T.W.J. & Allaart, C.F. (2013), Drug Free Holiday In Patients With Rheumatoid Arthritis (RA): patients' Opinion, Arthritis and Rheumatism 65: S569-S569.
- Markusse, I.M.; Han, K.H.; Peeters, A.J.; Ronday, H.K.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Lems, W.F. & Allaart, C.F. (2013), Initial Combination Therapy In Early Rheumatoid Arthritis: Which Patients Benefit?, Arthritis and Rheumatism 65: S570-S570.
- Muhammad, A.; Wesemael, T. van; Kochi, Y.; Mjaavatten, M.; Wevers-de-Boer, K.; Allaart, C.F.; Trouw, L.A.; Suzuki, A.; Yamamoto, K.; Helm-van Mil, A.H.M. van der; Huizinga, T.W.J.; Toes, R.E.M. & Woude, D. van der (2013), In Rheumatoid Arthritis, Smoking Is Not Primarily Associated With Anti-Citrullinated Protein Antibodies, But With The Presence Of Multiple Autoantibodies, Arthritis and Rheumatism 65: S1024-S1024.
- Muller, P.C.E.H.; Budding, A.E.; Allaart, C.F.; Brinkman, D.M.C.; Kuijpers, T.W.; Westedt, M.; Berg, J.M. van den; Suijlekom-Smit, L.W.A. van; Rossum, M.A.J. van; Meij, T.G.J. de & Cate, R. ten (2013), Intestinal Microbiome In Polyarticular Juvenile Idiopathic Arthritis: A PILOT Study, Arthritis and Rheumatism 65: S934-S934.
- Wevers-De Boer, K.V.C.; Heimans, L.; Huizinga, T. & Allaart, C. (2013), Drug therapy in undifferentiated arthritis: a systematic literature review, Annals of the Rheumatic Diseases 72(9): 1436-1444.
- Heimans, L.; Broek, M. van den; Cessie, S. le; Siegerink, B.; Riyazi, N.; Han, K.H.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Lems, W.F. & Allaart, C.F. (2013), Association of High Body Mass Index With Decreased Treatment Response to Combination Therapy in Recent-Onset Rheumatoid Arthritis Patients.
- Mirkov, M.U.; Cui, J.; Vermeulen, S.H.; Stahl, E.A.; Toonen, E.J.M.; Makkinje, R.R.; Lee, A.T.; Huizinga, T.W.J.; Allaart, R.; Barton, A.; Mariette, X.; Miceli, C.R.; Criswell, L.A.; Tak, P.P.; Vries, N. de; Saevarsdottir, S.; Padyukov, L.; Bridges, S.L.; Schaardenburg, D.J. van; Jansen, T.L.; Dutmer, E.A.J.; Laar, M.A.F.J.V. de; Barrera, P.; Radstake, T.R.D.J.; Riel, P.L.C.M. van; Scheffer, H.; Franke, B.; Brunner, H.G.; Plenge, R.M.; Gregersen, P.K.; Guchelaar, H.J. & Coenen, M.J.H. (2013), Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis, Annals of the Rheumatic Diseases 72(8): 1375-1381.
- Nies, J.A.B. van; Brouwer, E.; Gaalen, F.A. van; Allaart, C.F.; Huizinga, T.W.J.; Posthumus, M.D. & Helm-van Mil, A.H.M. van der (2013), Improved early identification of arthritis: evaluating the efficacy of Early Arthritis Recognition Clinics, Annals of the Rheumatic Diseases 72(8): 1295-1301.
- Allaart, C.F.; Lems, W.F. & Huizinga, T.W.J. (2013), The BeSt way of withdrawing biologic agents, Clinical and Experimental Rheumatology 31(4): S14-S18.
- Hirata, S.; Dirven, L.; Shen, Y.J.; Centola, M.; Cavet, G.; Lems, W.F.; Tanaka, Y.; Huizinga, T.W.J. & Allaart, C.F. (2013), A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study, Rheumatology 52(7): 1202-1207.
- Gvozdenovic, E.; Koevoets, R.; Langenhoff, J.; Allaart, R. & Landewe, R. (2013), COMPARISON OF CHARACTERISTICS OF INTERNATIONAL AND NATIONAL DATABASES IN RHEUMATOID ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW, Annals of the Rheumatic Diseases 72: 412-412.
- Wevers-De Boer, K.V.C.; Heimans, L.; Visser, K.; Schouffoer, A.; Oosterhout, M. van; Groenendaal, H. van; Speyer, I.; Huizinga, T. & Allaart, C. (2013), DRUG FREE REMISSION AFTER ONE YEAR OF TREATMENT IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: ALSO POSSIBLE FOR ACPA POSITIVE PATIENTS?, Annals of the Rheumatic Diseases 72: 114-114.
- Wevers-De Boer, K.V.C.; Heimans, L.; Visser, K.; Kalvesten, J.; Goekoop, R.; Molenaar, E.; Buck, M. de; Huizinga, T. & Allaart, C. (2013), EARLY METACARPAL BONE MINERAL DENSITY LOSS IS PREDICTIVE FOR RADIOLOGIC JOINT DAMAGE PROGRESSION AFTER 1 YEAR IN PATIENTS WITH EARLY ARTHRITIS, Annals of the Rheumatic Diseases 72: 549-549.
- Ferraccioli, G.; Lapadula, G.; Dougados, M.; Veale, D.J.; Huizinga, T.W.; Allaart, C.F.; Landewe, R.B.; Silva, J.A.P. da; Mola, E.M.; Moots, R.J.; Kay, J.; Salomon-Escoto, K.I. & Heijde, D. van der (2013), HAQ BASELINE VALUES IN AN INTERNATIONAL REGISTRY OF RA PATIENTS DURING THE ERA OF BIOLOGIC TERAPIES: THE 2013 METEOR DATABASE., Annals of the Rheumatic Diseases 72: 402-402.
- Koevoets, R.; Dirven, L.; Klarenbeek, N.B.; Krugten, M.V. van; Ronday, H.K.; Heijde, D.M.F.M. van der; Huizinga, T.W.J.; Kerstens, P.S.J.M.; Lems, W.F. & Allaart, C.F. (2013), 'Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA', Annals of the Rheumatic Diseases 72(6): 870-874.
- Heimans, L.; Wevers-de Boer, K.V.; Visser, K.; Goekoop-Ruiterman, Y.P.; Molenaar, T.H.; Harbers, J.B.; Bijkerk, C.; Speyer, I.; Buck, P.D. de; Sonnaville, P.B. de; Grillet, B.A.; Huizinga, T.W. & Allaart, C.F. (2013), OUTCOMES OF TWO YEARS OF REMISSION STEERED TREATMENT IN EARLY ARTHRITIS PATIENTS, Annals of the Rheumatic Diseases 72: 401-401.
- Broek, M. van den; Visser, K.; Allaart, C.F. & Huizinga, T.W.J. (2013), Personalized medicine: predicting responses to therapy in patients with RA, Current Opinion in Pharmacology 13(3): 463-469.
- Allaart, C.F. (2013), RHEUMATOID ARTHRITIS REMISSION CRITERIA IN PRACTICE AND STUDIES, Annals of the Rheumatic Diseases 72: 15-15.
- Broek, M. van den; Allaart, C.F.; Brines, M.; Cerami, A. & Huizinga, T.W. (2013), SAFETY AND EFFICACY OF ARA290, A NON-HEMATOPOIETIC ERYTHROPOIETIN DERIVED PEPTIDE, IN A 4 WEEKS PHASE II OPEN LABEL TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS, Annals of the Rheumatic Diseases 72: 620-620.
- Muhammad, A.; Wesemael, T. van; Kochi, Y.; Mjaavatten, M.; Wevers-de Boer, K.; Allaart, C.; Trouw, L.; Suzuki, A.; Yamamoto, K.; Huizinga, T.; Toes, R. & Woude, D. van der (2013), SMOKING IS NOT PRIMARILY ASSOCIATED WITH ACPA, BUT WITH THE PRESENCE OF MULTIPLE AUTOANTIBODIES IN RA, Annals of the Rheumatic Diseases 72: 117-117.
- Koevoets, R.; Glas, N.A. de; Bourlout, C. le; Huizinga, T.W.J.; Allaart, C.F.; Dougados, M. & Gossec, L. (2013), Autonomous online health assessment questionnaire registry in daily clinical practice, Rheumatology 52(5): 883-887.
- Broek, M. van den; Dirven, L.; Kroon, H.M.; Kloppenburg, M.; Ronday, H.K.; Peeters, A.J.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Lems, W.F. & Allaart, C.F. (2013), Early Local Swelling and Tenderness Are Associated with Large-joint Damage After 8 Years of Treatment to Target in Patients with Recent-onset Rheumatoid Arthritis.
- Dirven, L.; Klarenbeek, N.B.; Broek, M. van den; Groenendael, J.H.L.M. van; Sonnaville, P.B.J. de; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Dijkmans, B.A.C.; Lems, W.F. & Allaart, C.F. (2013), Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy, Clinical Rheumatology 32(5): 585-590.
- Cui, J.; Stahl, E.A.; Saevarsdottir, S.; Miceli, C.; Diogo, D.; Trynka, G.; Raj, T.; Mirkov, M.U.; Canhao, H.; Ikari, K.; Terao, C.; Okada, Y.; Wedren, S.; Askling, J.; Yamanaka, H.; Momohara, S.; Taniguchi, A.; Ohmura, K.; Matsuda, F.; Mimori, T.; Gupta, N.; Kuchroo, M.; Morgan, A.W.; Isaacs, J.D.; Wilson, A.G.; Hyrich, K.L.; Herenius, M.; Doorenspleet, M.E.; Tak, P.P.; Crusius, J.B.A.; Horst-Bruinsma, I.E. van der; Wolbink, G.J.; Riel, P.L.C.M. van; Laar, M. van de; Guchelaar, H.J.; Shadick, N.A.; Allaart, C.F.; Huizinga, T.W.J.; Toes, R.E.M.; Kimberly, R.P.; Bridges, S.L.; Criswell, L.A.; Moreland, L.W.; Fonseca, J.E.; Vries, N. de; Stranger, B.E.; Jager, P.L. de; Raychaudhuri, S.; Weinblatt, M.E.; Gregersen, P.K.; Mariette, X.; Barton, A.; Padyukov, L.; Coenen, M.J.H.; Karlson, E.W. & Plenge, R.M. (2013), Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis, PLoS Genetics 9(3).
- Boers, M.; Tuyl, L. van; Broek, M. van den; Kostense, P.J. & Allaart, C.F. (2013), Meta-analysis suggests that intensive non-biological combination therapy with step-down prednisolone (COBRA strategy) may also 'disconnect' disease activity and damage in rheumatoid arthritis, Annals of the Rheumatic Diseases 72(3): 406-409.
- Aken, J. van; Heimans, L.; Gillet-van Dongen, H.; Visser, K.; Ronday, H.K.; Speyer, I.; Peeters, A.J.; Huizinga, T.W.J. & Allaart, C.F. (2013), Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study)., Annals of the Rheumatic Diseases.
- Dirven, L.; Huizinga, T.W.J. & Allaart, C.F. (2012), Risk factors for reported influenza and influenza-like symptoms in patients with rheumatoid arthritis, Scandinavian Journal of Rheumatology 41(5): 359-365.
- Dirven, L.; Visser, K.; Klarenbeek, N.B.; Ewals, J.A.P.M.; Han, K.H.; Peeters, A.J.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Dijkmans, B.A.C. & Allaart, C.F. (2012), Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression, Scandinavian Journal of Rheumatology 41(1): 15-19.
- Gvozdenovic, E.; Koevoets, R.; Wolterbeek, R.; Heijde, D. van der; Huizinga, T.W.J.; Allaart, C.F. & Landewe, R.B.M. (2012), Assessment of Global Disease Activity in Rheumatoid Arthritis Patients Monitored in the Measurement of Efficacy of Treatment in the Era of Rheumatology Database: The patient's Versus the rheumatologist's Opinion, Arthritis and Rheumatism 64(10): S173-S174.
- Heimans, L.; Wevers-de Boer, K.V.C.; Visser, K.; Ronday, H.K.; Oosterhout, M. van; Groenendael, J.H.L.M. van; Peeters, A.J.; Steup-Beekman, G.; Collee, G.; Sonnaville, P.B.J.; Grillet, B.A.; Huizinga, T. & Allaart, C.F. (2012), Clinical and Radiological Outcomes After One Year of Remission Steered Combination Treatment in Patients with Early Rheumatoid and Undifferentiated Arthritis., Arthritis and Rheumatism 64(10): S680-S680.
- Dirven, L.; Broek, M. van den; Peeters, A.J.; Riyazi, N.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Allaart, C.F. & Lems, W.F. (2012), Five Years of Treatment to Target in Early Active Rheumatoid Arthritis: Prevalence and Predictors of Vertebral Fractures, Arthritis and Rheumatism 64(10): S840-S840.
- Broek, M. van den; Heimans, L.; Cessie, S. le; Siegerink, B.; Ronday, H.K.; Han, K.H.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Lems, W.F. & Allaart, C.F. (2012), High Body Mass Index Is Associated with Decreased Response to Initial Combination Therapy in Recent Onset RA Patients., Arthritis and Rheumatism 64(10): S573-S573.
- Gvozdenovic, E.; Dirven, L.; Broek, M. van den; Han, K.; Molenaar, T.H.E.; Landewe, R.; Lems, W.F. & Allaart, C.F. (2012), Intra Articular Injections in Patients with Rheumatoid Arthritis: Analyses From the Behandelstrategien Study, Arthritis and Rheumatism 64(10): S204-S204.
- Heimans, L.; Wevers-de Boer, K.V.C.; Visser, K.; Goekoop, R.; Molenaar, T.H.E.; Grillet, B.A.; Huizinga, T. & Allaart, C.F. (2012), Patient Reported Outcomes in Early Arthritis Patients, Arthritis and Rheumatism 64(10): S1103-S1104.
- Muller, P.C.E.H.; Yildiz, B.; Allaart, C.F.; Brinkman, D.M.C.; Rossum, M.A.J. van; Berg, J.M. van den; Suijlekom-Smit, L.W.A. van; Cate, R. ten & Vries, M.C. de (2012), Randomized Clinical Trial in Pediatric Rheumatology: Are Parents and Patients in Equipoise?, Arthritis and Rheumatism 64(10): S849-S849.
- Wevers-de Boer, K.V.C.; Heimans, L.; Visser, K.; Schouffoer, A.A.; Molenaar, T.H.E.; Harbers, J.B.; Bijkerk, C.; Speyer, I.; Buck, M. de; Sonnaville, P.B. de; Grillet, B.A.; Huizinga, T. & Allaart, C.F. (2012), Remission After One Year in ACPA Positive and ACPA Negative Patients with Early Arthritis, Arthritis and Rheumatism 64(10): S172-S172.
- Dirven, L.; Huizinga, T.W.J. & Allaart, C.F. (2012), Risk factors for reported influenza and influenza-like symptoms in patients with rheumatoid arthritis., Scandinavian Journal of Rheumatology 41(5): 359-65.
- Broek, M. van den; Lems, W.F. & Allaart, C.F. (2012), BeSt practice: the success of early-targeted treatment in rheumatoid arthritis., Clinical and Experimental Rheumatology.
- Broek, M. van den; Lems, W.F. & Allaart, C.F. (2012), Do we need guidelines to stop as well as to start biological therapies for rheumatoid arthritis?, Clinical and Experimental Rheumatology.
- Broek, M. van den; Dirven, L.; Vries-Bouwstra, J.K. de; Dehpoor, A.J.; Goekoop-Ruiterman, Y.P.M.; Gerards, A.H.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Lems, W.F. & Allaart, C.F. (2012), Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up, Annals of the Rheumatic Diseases 71(9): 1530-1533.
- Wavers-de Boer, K.; Visser, K.; Heimans, L.; Ronday, H.K.; Molenaar, E.; Groenendael, J.H.L.M.; Peeters, A.J.; Westedt, M.L.; Collee, G.; Sonnaville, P.B.J. de; Grillet, B.A.M.; Huizinga, T.W.J. & Allaart, C.F. (2012), Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study), Annals of the Rheumatic Diseases 71(9): 1472-1477.
- Nies, J.A.B. van; Brouwer, E.; Gaalen, F.A. van; Allaart, C.F.; Huizinga, T.W.J.; Posthumus, M.D. & Helm-van Mil, A.H.M. van der (2012), Improved early identification of arthritis: evaluating the efficacy of Early Arthritis Recognition Clinics., Annals of the Rheumatic Diseases.
- Dirven, L.; Broek, M. van den; Kroon, H.M.; Grillet, B.A.M.; Han, K.H.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Lems, W.F. & Allaart, C.F. (2012), Large-joint damage in patients with early rheumatoid arthritis and its association with treatment strategy and damage of the small joints., Rheumatology.
- Broek, M. van den; Lems, W.F. & Allaart, C.F. (2012), BeSt practice: the success of early-targeted treatment in rheumatoid arthritis, Clinical and Experimental Rheumatology 30(4): S35-S38.
- Broek, M. van den; Lems, W.F. & Allaart, C.F. (2012), Do we need guidelines to stop as well as to start biological therapies for rheumatoid arthritis?, Clinical and Experimental Rheumatology 30(4): S21-S26.
- Dirven, L.; Broek, M. van den; Groenendael, J.H.L.M. van; Beus, W.M. de; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Allaart, C.F. & Lems, W.F. (2012), Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis, BMC Musculoskeletal Disorders 13: -.
- Koevoets, R.; Dirven, L.; Klarenbeek, N.B.; Krugten, M.V. van; Ronday, H.K.; Heijde, D.M.F.M. van der; Huizinga, T.W.J.; Kerstens, P.S.J.M.; Lems, W.F. & Allaart, C.F. (2012), 'Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA', Annals of the Rheumatic Diseases.
- Woude, D. van der; Visser, K.; Klarenbeek, N.B.; Ronday, H.K.; Peeters, A.J.; Kerstens, P.J.S.M.; Dijkmans, B.A.C.; Huizinga, T.W.J.; Helm-van Mil, A.H.M. van der & Allaart, C.F. (2012), Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies, Rheumatology 51(6): 1120-1128.
- Broek, M. van den; Dirven, L.; Klarenbeek, N.B.; Molenaar, T.H.E.; Han, K.H.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Dijkmans, B.A.C. & Allaart, C.F. (2012), The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study, Annals of the Rheumatic Diseases 71(2): 245-248.
- Dirven, L.; Guler-Yuksel, M.; Beus, W.M. de; Ronday, H.K.; Speyer, I.; Huizinga, T.W.J.; Dijkmans, B.A.C.; Allaart, C.F. & Lems, W.F. (2011), Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: Bone mineral density measurements in a multicenter randomized clinical trial.
- Broek, M. van den; Dirven, L.; Klarenbeek, N.B.; Molenaar, T.H.E.; Han, K.H.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Dijkmans, B.A.C. & Allaart, C.F. (2011), The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study., Annals of the Rheumatic Diseases.
- Dirven, L.; Visser, K.; Klarenbeek, N.B.; Ewals, J.A.P.M.; Han, K.H.; Peeters, A.J.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Dijkmans, B.A.C. & Allaart, C.F. (2011), Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression., Scandinavian Journal of Rheumatology.
- Allaart, C.F.; Dirven, L.; Hirata, S.; Kerstens, P.J.S.M.; Dijkmans, B.A.C.; Chernoff, D.; Cavet, G.; Centola, M.; Hesterberg, L.K.; Tanaka, Y.; Huizinga, T.W.J. & Shen, Y.J. (2011), A Multi-Biomarker Disease Activity (Vectra DA) Algorithm Score for Rheumatoid Arthritis Predicts Radiographic Progression in the BeSt Study, Arthritis and Rheumatism 63(10): S630-S630.
- Hirata, S.; Dirven, L.; Cavet, G.; Shen, Y.J.; Centola, M.; Lems, W.F.; Huizinga, T.W.J.; Allaart, C.F. & Tanaka, Y. (2011), A Novel Multi-Biomarker Disease Activity Score (Vectra (TM) DA algorithm score) Reflects Clinical Disease Activity Score and Health Assessment Questionnaire for Rheumatoid Arthritis in the BeSt Study, Arthritis and Rheumatism 63(10): S132-S132.
- Klarenbeek, N.B.; Koevoets, R.; Heijde, D.M.F.M. van der; Gerards, A.H.; Wolde, S. ten; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Dijkmans, B.A.C. & Allaart, C.F. (2011), Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis, Annals of the Rheumatic Diseases 70(10): 1815-1821.
- Heimans, L.; Broek, M. van den; Dirven, L.; Schouffoer, A.A.; Speyer, I.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Lems, W.F. & Allaart, C.F. (2011), Body Mass Index Is Associated with Decreased Response to Initial and Delayed Treatment with Dose Escalated Infliximab in Patients with Recent Onset Rheumatoid Arthritis., Arthritis and Rheumatism 63(10): S156-S157.
- Dirven, L.; Broek, M. van den; Klarenbeek, N.B.; Han, K.H.; Ronday, H.K.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Lems, W.F. & Allaart, C.F. (2011), Eight Year Results of Disease Activity Steered Treatment in a Large Recent Rheumatoid Arthritis Cohort: Clinical and Radiological Outcomes, Arthritis and Rheumatism 63(10): S858-S858.
- Broek, M. van den; Dirven, L.; Kroon, H.M.; Oosterhout, M. van; Han, K.H.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Lems, W.F. & Allaart, C.F. (2011), Local Swelling and Prolonged Local Pain in a Large Joint Are Independent Predictors of Damage in That Joint in Recent Onset Rheumatoid Arthritis Patients, Arthritis and Rheumatism 63(10): S133-S133.
- Boers, M.; Tuyl, L.H.D. van; Broek, M. van den; Kostense, P.J. & Allaart, C.F. (2011), Meta-Analysis Suggests Intensive Non-Biologic Combination Therapy with Step-Down Prednisolone May Also 'Disconnect' Disease Activity and Damage in Rheumatoid Arthritis., Arthritis and Rheumatism 63(10): S497-S497.
- Heimans, L.; Wevers-de Boer, K.V.C.; Visser, K.; Huizinga, T.W.J.; Ronday, H.K.; Westedt, M.L.; Molenaar, T.H.E.; Mast, R.C. van der & Allaart, C.F. (2011), Optimism and Depressive Scores in Early Arthritis Patients Before and After Treatment with Methotrexate and a Tapered High Dose of Prednisone in the IMPROVED Study, Arthritis and Rheumatism 63(10): S861-S861.
- Broek, M. van den; Dirven, L.; Dehpoor, A.J.; Vries-Bouwstra, J.K. de; Goekoop-Ruiterman, Y.P.; Peeters, A.J.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Lems, W.F. & Allaart, C.F. (2011), Rapid Radiological Progression in the First Year of Rheumatoid Arthritis Predicts Both Disability and Radiological Joint Damage Progression Over 8 Years of Targeted Treatment., Arthritis and Rheumatism 63(10): S157-S158.
- Wevers-de Boer, K.V.C.; Heimans, L.; Visser, K.; Ronday, H.K.; Molenaar, T.H.E.; Seys, P.E.H.; Bijkerk, C.; Westedt, M.L.; Beus, W. de; Sonnaville, P.B. de; Huizinga, T. & Allaart, C.F. (2011), Remission Induction Therapy with Methotrexate and Prednisone in Patients with Early Rheumatoid and Undifferentiated Arthritis., Arthritis and Rheumatism 63(10): S167-S168.
- Guler-Yuksel, M.; Bijsterbosch, J.; Allaart, C.F.; Meulenbelt, I.; Kroon, H.M.; Watt, I.; Lems, W.F. & Kloppenburg, M. (2011), Accelerated metacarpal bone mineral density loss is associated with radiographic progressive hand osteoarthritis, Annals of the Rheumatic Diseases 70(9): 1625-1630.
- Guler-Yuksel, M.; Bijsterbosch, J.; Allaart, C.F.; Meulenbelt, I.; Kroon, H.M.; Watt, I.; Lems, W.F. & Kloppenburg, M. (2011), Accelerated metacarpal bone mineral density loss is associated with radiographic progressive hand osteoarthritis., Annals of the Rheumatic Diseases 70(9): 1625-30.
- Dirven, L.; Guler-Yuksel, M.; Beus, W.M. de; Ronday, H.K.; Speyer, I.; Huizinga, T.W.J.; Dijkmans, B.A.C.; Allaart, C.F. & Lems, W.F. (2011), Changes in hand bone mineral density are associated with the level of disease activity in patients with rheumatoid arthritis: Bone mineral density measurements in the best study.
- Broek, M. van den; Klarenbeek, N.B.; Dirven, L.; Schaardenburg, D. van; Hulsmans, H.M.J.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Dijkmans, B.A.C. & Allaart, C.F. (2011), Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study, Annals of the Rheumatic Diseases 70(8): 1389-1394.
- Koevoets, R.; Klarenbeek, N.B.; Guler-Yuksel, M.; Oosterhout, M. van; Krugten, M.V. van; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Dijkmans, B.A.C.; Heijde, D.M.F.M. van der & Allaart, C.F. (2011), Simplified versions of the original disease activity score: validation in the BeSt trial, Annals of the Rheumatic Diseases 70(8): 1471-1474.
- Klarenbeek, N.B.; Guler-Yuksel, M.; Kooij, S.M. van der; Han, K.H.; Ronday, H.K.; Kerstens, P.J.S.M.; Seys, P.E.H.; Huizinga, T.W.J.; Dijkmans, B.C. & Allaart, C.F. (2011), The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study, Annals of the Rheumatic Diseases 70(6): 1039-1046.
- Broek, M. van den; Huizinga, T.W.J.; Dijkmans, B.C. & Allaart, C.F. (2011), Drug-free remission: is it already possible?, Current Opinion in Rheumatology 23(3): 266-272.
- Meeuwisse, C.M.; Linden, M.P. van der; Rullmann, T.A.; Allaart, C.F.; Nelissen, R.; Huizinga, T.W.; Garritsen, A.; Toes, R.E.; Schaik, R. van & Helm-van Mil, A.H. van der (2011), Identification of CXCL13 as a Marker for Rheumatoid Arthritis Outcome Using an In Silico Model of the Rheumatic Joint, Arthritis and Rheumatism 63(5): 1265-1273.
- Allaart, C.F. & Huizinga, T.W.J. (2011), Treatment strategies in recent onset rheumatoid arthritis, Current Opinion in Rheumatology 23(3): 241-244.
- Klarenbeek, N.B.; Guler-Yuksel, M.; Heijde, D.M.F.M. van der; Kerstens, P.J.S.M.; Mallee, C.; Westedt, M.L.; Huizinga, T.W.J.; Dijkmans, B.A.C. & Allaart, C.F. (2011), A comparison between the simplified erosion and narrowing score and the Sharp-van der Heijde score: post hoc analysis from the BeSt study, Annals of the Rheumatic Diseases 70(4): 714U214.
- Felson, D.T.; Smolen, J.S.; Wells, G.; Zhang, B.; Tuyl, L.H.D. van; Funovits, J.; Aletaha, D.; Allaart, C.F.; Bathon, J.; Bombardieri, S.; Brooks, P.; Brown, A.; Matucci-Cerinic, M.; Choi, H.; Combe, B.; Wit, M. de; Dougados, M.; Emery, P.; Furst, D.; Gomez-Reino, J.; Hawker, G.; Keystone, E.; Khanna, D.; Kirwan, J.; Kvien, T.K.; Landewe, R.; Listing, J.; Michaud, K.; Martin-Mola, E.; Montie, P.; Pincus, T.; Richards, P.; Siegel, J.N.; Simon, L.S.; Sokka, T.; Strand, V.; Tugwell, P.; Tyndall, A.; Heijde, D. van der; Verstappen, S.; White, B.; Wolfe, F.; Zink, A. & Boers, M. (2011), American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials, Arthritis and Rheumatism 63(3): 573-586.
- Felson, D.T.; Smolen, J.S.; Wells, G.; Zhang, B.; Tuyl, L.H.D. van; Funovits, J.; Aletaha, D.; Allaart, C.F.; Bathon, J.; Bombardieri, S.; Brooks, P.; Brown, A.; Matucci-Cerinic, M.; Choi, H.; Combe, B.; Wit, M. de; Dougados, M.; Emery, P.; Furst, D.; Gomez-Reino, J.; Hawker, G.; Keystone, E.; Khanna, D.; Kirwan, J.; Kvien, T.K.; Landewe, R.; Listing, J.; Michaud, K.; Martin-Mola, E.; Montie, P.; Pincus, T.; Richards, P.; Siegel, J.N.; Simon, L.S.; Sokka, T.; Strand, V.; Tugwell, P.; Tyndall, A.; Heijde, D. van der; Verstappen, S.; White, B.; Wolfe, F.; Zink, A. & Boers, M. (2011), American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials, Annals of the Rheumatic Diseases 70(3): 404-413.
- Klarenbeek, N.B.; Kooij, S.M. van der; Guler-Yuksel, M.; Groenendael, J.H.L.M. van; Han, K.H.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Dijkmans, B.A.C. & Allaart, C.F. (2011), Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study, Annals of the Rheumatic Diseases 70(2): 315-319.
- Klarenbeek, N.B.; Kooij, S.M. van der; Guler-Yuksel, M.; Groenendael, J.H.L.M. van; Han, K.H.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Dijkmans, B.A.C. & Allaart, C.F. (2011), Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study., Annals of the Rheumatic Diseases 70(2): 315-9.
- Allaart, C.F. & Huizinga, T.W.J. (2011), Treatment strategies in recent onset rheumatoid arthritis.
- Kooi, E. van der; Klarenbeek, N.B.; Guler-Yuksel, M.; Kerstens, P.J.S.M.; Lubbe, P.A.H.M. van der; Westedt, M.L.; Wolde, S. ten; Huizinga, T.W.J.; Dijkmans, B.A.C. & Allaart, C.F. (2011), A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt study, Annals of the Rheumatic Diseases 70(1): 168-171.
- Guler-Yuksel, M.; Klarenbeek, N.B.; Goekoop-Ruiterman, Y.P.M.; Vries-Bouwstra, J.K. de; Kooij, S.M. van der; Gerards, A.H.; Ronday, H.K.; Huizinga, T.W.J.; Dijkmans, B.A.C.; Allaart, C.F. & Lems, W.F. (2010), Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis, Arthritis Research and Therapy 12(3).
- Klarenbeek, N.B.; Guler-Yuksel, M.; Heijde, D.M.F.M. van der; Hulsmans, H.M.J.; Kerstens, P.J.S.M.; Molenaar, T.H.E.; Sonnaville, P.B.J. de; Huizinga, T.W.J.; Dijkmans, B.A.C. & Allaart, C.F. (2010), Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab, Annals of the Rheumatic Diseases 69(12): 2107-2113.
- Koevoets, R.; Allaart, C.F.; Heijde, D.M.F.M. van der & Huizinga, T.W.J. (2010), Disease Activity Monitoring in Rheumatoid Arthritis in Daily Practice: Experiences with METEOR, a Free Online Tool, Journal of Rheumatology 37(12): 2632-2633.
- Klarenbeek, N.B.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Dijkmans, B.A.C. & Allaart, C.F. (2010), Recent advances in the management of rheumatoid arthritis, British medical journal 341.
- Klarenbeek, N.B.; Guler-Yuksel, M.; Heijde, D.M.F.M. van der; Kerstens, P.J.S.M.; Mallee, C.; Westedt, M.L.; Huizinga, T.W.J.; Dijkmans, B.A.C. & Allaart, C.F. (2010), A comparison between the simplified erosion and narrowing score and the Sharp-van der Heijde score: post hoc analysis from the BeSt study., Annals of the Rheumatic Diseases.
- Guler-Yuksel, M.; Allaart, C.F.; Watt, I.; Goekoop-Ruiterman, Y.P.M.; Vries-Bouwstra, J.K. de; Schaardenburg, D. van; Krugten, M.V. van; Dijkmans, B.A.C.; Huizinga, T.W.J.; Lems, W.F. & Kloppenburg, M. (2010), Treatment with TNF-alpha inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis, Osteoarthritis and Cartilage 18(10): 1256-1262.
- Guler-Yuksel, M.; Allaart, C.F.; Watt, I.; Goekoop-Ruiterman, Y.P.M.; Vries-Bouwstra, J.K. de; Schaardenburg, D. van; Krugten, M.V. van; Dijkmans, B.A.C.; Huizinga, T.W.J.; Lems, W.F. & Kloppenburg, M. (2010), Treatment with TNF-α inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis., Osteoarthritis and Cartilage 18(10): 1256-62.
- Visser, K.; Allaart, C.F. & Huizinga, T.W.J. (2010), Use of methotrexate in undifferentiated arthritis., Clinical and Experimental Rheumatology 28(5 Suppl 61): S117-21.
- Visser, K.; Allaart, C.F. & Huizinga, T.W.J. (2010), Use of methotrexate in undifferentiated arthritis, Clinical and Experimental Rheumatology 28(5): S117S121.
- Visser, K.; Goekoop-Ruiterman, Y.P.M.; Vries-Bouwstra, J.K. de; Ronday, H.K.; Seys, P.E.H.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Dijkmans, B.A.C. & Allaart, C.F. (2010), A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study, Annals of the Rheumatic Diseases 69(7): 1333-1337.
- Klarenbeek, N.B.; Kooij, S.M. van der; Huizinga, T.J.W.; Goekoop-Ruiterman, Y.P.M.; Hulsmans, H.M.J.; Krugten, M.V. van; Speyer, I.; Vries-Bouwstra, J.K. de; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Dijkmans, B.A.C. & Allaart, C.F. (2010), Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial, Annals of the Rheumatic Diseases 69(7): 1342-1345.
- Cui, J.; Saevarsdottir, S.; Thomson, B.; Padyukov, L.; Helm-van Mil, A.H.M. van der; Nititham, J.; Hughes, L.B.; Vries, N. de; Raychaudhuri, S.; Alfredsson, L.; Askling, J.; Wedren, S.; Ding, B.; Guiducci, C.; Wolbink, G.J.; Crusius, J.B.A.; Horst-Bruinsma, I.E. van der; Herenius, M.; Weinblatt, M.E.; Shadick, N.A.; Worthington, J.; Batliwalla, F.; Kern, M.; Morgan, A.W.; Wilson, A.G.; Isaacs, J.D.; Hyrich, K.; Seldin, M.F.; Moreland, L.W.; Behrens, T.W.; Allaart, C.F.; Criswell, L.A.; Huizinga, T.W.J.; Tak, P.P.; Bridges, S.L.; Toes, R.E.M.; Barton, A.; Klareskog, L.; Gregersen, P.K.; Karlson, E.W.; Plenge, R.M. & Biol Rheumatoid Arthrit Genet & Ge (2010), Rheumatoid Arthritis Risk Allele PTPRC Is Also Associated With Response to Anti-Tumor Necrosis Factor alpha Therapy, Arthritis and Rheumatism 62(7): 1849-1861.
- Bijl, A.E. van der & Allaart, C.F. (2010), Efficacy of intraarticular infliximab administration in patients with recurrent gonarthritis: comment on the article by van der Bijl et al Reply, ARTHRITIS CARE & RESEARCH 62(2): 291-292.
- Kooloos, W.M.; Wessels, J.A.M.; Straaten, T. van der; Allaart, C.F.; Huizinga, T.W.J. & Guchelaar, H.J. (2010), Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis, Pharmacogenomics 11(2): 163-175.
- Goekoop-Ruiterman, Y.P.M.; Vries-Bouwstra, J.K. de; Kerstens, P.J.S.M.; Nielen, M.M.J.; Vos, K.; Schaardenburg, D. van; Speyer, I.; Seys, P.E.H.; Breedveld, F.C.; Allaart, C.F. & Dijkmans, B.A.C. (2010), DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis, Annals of the Rheumatic Diseases 69(1): 65-69.
- van den Hout WB, Goekoop-Ruiterman YPM, Allaart CF, Kerstens PJSM & Dijkmans BAC (2009), The cost-utility analysis of the BeSt trial: is a camel in fact a horse with abnormalities in the distribution of dorsal fat? Comment on the article by van den Hout et al Reply, Arthritis and Rheumatism 61(11): 1617-1618.
- Kooloos WM, Wessels JAM, van der Kooij SM, Allaart CF, Huizinga TWJ & Guchelaar HJ (2009), Optimalisation of the clinical pharmacogenetic model to predict methotrexate treatment response: the influence of the number of haplotypes of MTHFR 1298A-677C alleles on probability to respond, Annals of the Rheumatic Diseases 68(8): 1371-1371.
- Kooloos WM, Wessels JAM, van der Kooij SM, Allaart CF, Huizinga TWJ & Guchelaar HJ (2009), Optimalisation of the clinical pharmacogenetic model to predict methotrexate treatment response: the influence of the number of haplotypes of MTHFR 1298A-677C alleles on probability to respond, Annals of the Rheumatic Diseases 68(8): 1371-1371.
- van der Kooij SM, le Cessie S, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Zeben D, Kerstens PJ, Hazes JM, van Schaardenburg D, Breedveld FC, Dijkmans BA & Allaart CF (2009), Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis., Annals of the Rheumatic Diseases 68(7): 1153-8.
- van der Kooij SM, le Cessie S, Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, van Zeben D, Kerstens PJSM, Hazes JMW, van Schaardenburg D, Breedveld FC & Dijkmans BAC (2009), Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis, Annals of the Rheumatic Diseases 68(7): 1153-1158.
- Bijl, A.E. van der; Teng, Y.K.O.; Oosterhout, M. van; Breedveld, F.C.; Allaart, C.F. & Huizinga, T.W.J. (2009), Efficacy of Intraarticular Infliximab in Patients With Chronic or Recurrent Gonarthritis: A Clinical Randomized Trial, Arthritis and Rheumatism 61(7): 974-978.
- van der Kooij SM, Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Guler-Yuksel M, Zwinderman AH, Kerstens PJSM, van der Lubbe PAHM, de Beus WM, Grillet BAM, Ronday HK, Huizinga TWJ, Breedveld FC, Dijkmans BAC & Allaart CF (2009), Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis, Annals of the Rheumatic Diseases 68(6): 914-921.
- Klarenbeek NB, Allaart CF, Kerstens PJSM, Huizinga TWJ & Dijkmans BAC (2009), The BeSt story: on strategy trials in rheumatoid arthritis, Current Opinion in Rheumatology 21(3): 291-298.
- van Bemmel JM, Delgado V, Holman ER, Allaart CF, Huizinga TWJ, Bax JJ & van der Helm-van Mil AHM (2009), No Increased Risk of Valvular Heart Disease in Adult Poststreptococcal Reactive Arthritis, Arthritis and Rheumatism 60(4): 987-993.
- van Bemmel JM, Delgado V, Holman ER, Allaart CF, Huizinga TWJ, Bax JJ & van der Helm-van Mil AHM (2009), No Increased Risk of Valvular Heart Disease in Adult Poststreptococcal Reactive Arthritis, Arthritis and Rheumatism 60(4): 987-993.
- Guler-Yuksel M, Allaart CF, Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, van Groenendael JHLM, Mallee C, de Bois MHW, Breedveld FC, Dijkmans BAC & Lems WF (2009), Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis, Annals of the Rheumatic Diseases 68(3): 330-336.
- van den Hout WB, Goekoop-Ruiterman YPM, Allaart CF, de Vries-Bouwstra JK, Hazes JMM, Kerstens PJSM, van Zeben D, Hulsmans HMJ, de Jonge-Bok JM & de Sonnaville PBJ (2009), Cost-Utility Analysis of Treatment Strategies in Patients With Recent-Onset Rheumatoid Arthritis, Arthritis and Rheumatism 61(3): 291-299.
- van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YPM, Ewals JAPM, Han KH, Hazes JMW, Kerstens PJSM, Peeters AJ, van Zeben D & Breedveld FC (2009), Patient-Reported Outcomes in a Randomized Trial Comparing Four Different Treatment Strategies in Recent-Onset Rheumatoid Arthritis, Arthritis and Rheumatism 61(1): 4-12.
- van der Helm-van Mil AHM, van der Kooij SM, Allaart CF, Toes REM & Huizinga TWJ (2008), A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis, Annals of the Rheumatic Diseases 67(6).
- Guler-Yuksel M, Bijsterbosch J, Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Hulsmans HMJ, de Beus WM, Han KH, Breedveld FC, Dijkmans BAC, Allaart CF & Lems WF (2008), Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis, Annals of the Rheumatic Diseases 67(6).
- van der Kooij SM, Allaart CF, Dijkmans BAC & Breedveld FC (2008), Innovative treatment strategies for patients with rheumatoid arthritis, Current Opinion in Rheumatology 20(3).
- de Vries-Bouwstra JK, Goekoop-Ruiterman YPM, Verpoort KN, Schreuder GMT, Ewals JAPM, Terwiel JP, Ronday HK, Kerstens PJSM, Toes REM, de Vries RRP, Breedveld FC, Dijkmans BAC, Huizinga TWJ & Allaart CF (2008), Progression of joint damage in early rheumatoid arthritis, Arthritis and Rheumatism 58(5).
- van der Kooij SM, Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Peeters AJ, van Krugten MV, Breedveld FC, Dijkmans BAC & Allaart CF (2008), Probability of continued low disease activity in patients with recent onset rheumatoid arthritis treated according to the disease activity score, Annals of the Rheumatic Diseases 67(2).
- Zirkzee EJM, Sneep AC, de Buck PDM, Allaart CF, Peeters AJ, Ronday HK, Westedt ML, le Cessie S & Vlieland TPMV (2008), Sick leave and work disability in patients with early arthritis, Clinical Rheumatology 27(1).
- Zirkzee EJ, Sneep AC, de Buck PD, Allaart CF, Peeters AJ, Ronday HK, Westedt ML, le Cessie S & Vliet Vlieland TP (2008), Sick leave and work disability in patients with early arthritis., Clinical Rheumatology 27(1): 11-9.
- Verpoort KN, Cheung K, Ioan-Facsinay A, van der Helm-van Mil AHM, de Vries-Bouwstra JK, Allaart CF, Drijfhout JW, de Vries RRP, Breedveld FC, Huizinga TWJ, Pruijn GJM & Toes REM (2007), Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles, Arthritis and Rheumatism 56(12).
- Guler-Yuksel M, Bijsterbosch J, Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Ronday HK, Peeters AJ, de Jonge-Bok JM, Breedveld FC, Dijkmans BAC, Allaart CF & Lems WF (2007), Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis, Annals of the Rheumatic Diseases 66(11).
- Allaart CF, Breedveld FC & Dijkmans BAC (2007), Treatment of recent-onset rheumatoid arthritis: Lessons from the BeSt study, Journal of Rheumatology 34.
- van der Bijl AE, Allaart CF, Breedveld FC, Kerstens PJSM & Dijkmans BAC (2007), Why publish a secondary analysis of only one treatment group in the Behandelstrategieen voor Reumatoide Artritis trial? Comment on the article by van der Bijl et al - Reply, Arthritis and Rheumatism 56(11).
- van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YPM, van Zeben D, Kerstens PJSM, Gerards AH, van Groenendael JHLM, Hazes JMW, Breedveld FC, Allaart CF & Dijkmans BAC (2007), Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score, Annals of the Rheumatic Diseases 66(10).
- Kurreeman FAS, Padyukov L, Marques RB, Schrodi SJ, Seddighzadeh M, Stoeken-Rijsbergen G, van der Helm-van Mil AHM, Allaart CF, Verduyn W, Houwing-Duistermaat J, Alfredsson L, Begovich AB, Klareskog L, Huizinga TWJ & Toes REM (2007), A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis, PLoS Medicine 4(9).
- Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Allaart CF, Kerstens PJSM, Grillet BAM, de Jager MH, Han KH, Speyer I, van der Lubbe PAHM, Seys PEH, Breedveld FC & Dijkmans BAC (2007), Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial), Annals of the Rheumatic Diseases 66(9).
- de Vries-Bouwstra JK, Goekoop-Ruiterman YPM, Wesoly J, Hulsmans HJ, de Craen AJM, Breedveld FC, Dijkmans BAC, Allaart CF & Huizinga TWJ (2007), Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damage, Annals of the Rheumatic Diseases 66(8).
- van der Bijl AE, Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, ten Wolde S, Han KH, van Krugten MV, Allaart CF, Breedveld FC & Dijkmans BAC (2007), Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis, Arthritis and Rheumatism 56(7).
- Wessels JAM, van der Kooij SM, le Cessie S, Kievit W, Barerra P, Allaart CF, Huizinga TWJ & Guchelaar HJ (2007), A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis, Arthritis and Rheumatism 56(6).
- van Dongen H, van Aken J, Lard LR, Visser K, Ronday HK, Hulsmans HMJ, Speyer I, Westedt ML, Peeters AJ, Allaart CF, Toes REM, Breedveld FC & Huizinga TWJ (2007), Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis - A double-blind, randomized, placebo-controlled trial, Arthritis and Rheumatism 56(5).
- Wesoly J, Hu X, Thabet MM, Chang M, Uh H, Allaart CF, Toes REM, Houwing-Duistermaat JJ, Begovich AB & Huizinga TWJ (2007), The 620W allele is the PTPN22 genetic variant conferring susceptibility to RA in a Dutch population, Rheumatology 46(4).
- Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJSM, Hazes JMW, Zwinderman AH, Peeters AJ, de Jonge-Bok JM, Mallee C, de Beus WM, de Sonnaville PBJ, Ewals JAPM, Breedveld FC & Dijkmans BAC (2007), Comparison of treatment strategies in early rheumatoid arthritis - A randomized trial, Annals of Internal Medicine 146(6).
- van der Straaten RJHM, Wessels JAM, de Vries-Bouwstra JK, Goekoop-Ruiterman YPM, Allaart CF, Tiller M, Huizinga TWJ & Guchelaar HJ (2007), Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in metho trexate-treated rheumatoid arthritis patients, Pharmacogenomics 8(2).
- Allaart CF, Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Breedveld FC & Dijkmans BAC (2006), Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study, Clinical and Experimental Rheumatology 24(6).
- Wessels JAM, Kooloos WM, de Jonge R, de Vries-Bouwstra JK, Allaart CF, Linssen A, Collee G, de Sonnaville P, Lindemans J, Huizinga TWJ & Guchelaar HJ (2006), Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis, Arthritis and Rheumatism 54(9).
- de Vries-Bouwstra J, Le Cessie S, Allaart C, Breedveld F & Huizinga T (2006), Using predicted disease outcome to provide differentiated treatment of early rheumatoid arthritis, Journal of Rheumatology 33(9).
- Goekoop-Ruiterman YPM, Allaart CF, Breedveld FC, de Vries-Bowstra JK & Dijkmans BAC (2006), How should best strategy and tight control be translated into clinical practice? Comment on the article by Goekoop-Ruiterman et al - Reply, Arthritis and Rheumatism 54(7).
- Van der Kooij SM, De Vries-Bouwstra JK, Goekoop-Ruiterman YPM, Van Zeben D, Kerstens PJSM, Peeters AJ, De Jonge-Bok JM, Hazes JMW, Breedveld FC, Allaart CF & Dijkmans BAC (2006), Joint damage progression in early rheumatoid arthritis patients despite continued conventional treatment after failure on initial methotrexate, Annals of the Rheumatic Diseases 65: 347-348.
- Van der Bijl AE, Van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Breedveld FC, Allaart CF & Dijkmans BA (2006), Persistent good clinical response after tapering and discontinuation of initial infliximab therapy in patients with early rheumatoid arthritis: 3-year results from the best trial, Annals of the Rheumatic Diseases 65: 109-109.
- De Vries-Bouwstra JK, Goekoop-Ruiterman YPM, Verpoort KN, Schreuder GMT, De Bois MHW, Mallee C, Toes REM, De Vries RRP, Breedveld FC, Dijkmans BAC, Huizinga TWJ & Allaart CF (2006), The association of HLA class II antigens and anti-CCP antibodies with progression of joint damage is affected by early and targeted treatment of rheumatoid arthritis, Annals of the Rheumatic Diseases 65: 88-89.
- Wessels JAM, de Vries-Bouwstra JK, Heijmans BT, Slagboom PE, Goekoop-Ruiterman YPM, Allaart CF, Kerstens PJSM, van Zeben D, Breedveld FC, Dijkmans BAC, Huizinga TWJ & Guchelaar HJ (2006), Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes, Arthritis and Rheumatism 54(4).
- van Aken J, van Dongen H, le Cessie S, Allaart CF, Breedveld FC & Huizinga TWJ (2006), Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study, Annals of the Rheumatic Diseases 65(1).
- Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJSM, Hazes JMW, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JHLM, Lems WF, van Krugten MV, Breedveld FC & Dijkmans C (2005), Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study) - A randomized, controlled trial, Arthritis and Rheumatism 52(11).
- van der Bijl AE, Allaart CF, van Vugt JPP, van Duinen SG & Breedveld FC (2005), Rheumatoid vasculitis treated with infliximab, Journal of Rheumatology 32(8).
- Arend SM, Kuijper EJ, Allaart CF, Muller WH & van Dissel JT (2004), Cavitating pneumonia after treatment with infliximab and prednisone, European Journal of Clinical Microbiology and Infectious Diseases 23(8).
- van Aken J, van Bilsen JHM, Allaart CF, Huizinga TWJ & Breedveld FC (2003), The Leiden Early Arthritis Clinic, Clinical and Experimental Rheumatology 21(5).
- Goekoop YPM, Allaart CFR, Breedveld FC & Dijkmans BAC (2001), Combination therapy in rheumatoid arthritis, Current Opinion in Rheumatology 13(3).